Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?

Julie L Otte; Janet S Carpenter; Shalini Manchanda; Kevin L Rand; Todd C Skaar; Michael Weaver; Yelena Chernyak; Xin Zhong; Christele Igega; Carol Landis

doi:10.1002/cam4.356

. 2014 Nov 30;4(2):183–200. doi: 10.1002/cam4.356

Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?

Julie L Otte ^1,^✉, Janet S Carpenter ¹, Shalini Manchanda ², Kevin L Rand ³, Todd C Skaar ², Michael Weaver ¹, Yelena Chernyak ², Xin Zhong ², Christele Igega ¹, Carol Landis ⁴

PMCID: PMC4329003 PMID: 25449319

Abstract

Although sleep is vital to all human functioning and poor sleep is a known problem in cancer, it is unclear whether the overall prevalence of the various types of sleep disorders in cancer is known. The purpose of this systematic literature review was to evaluate if the prevalence of sleep disorders could be ascertained from the current body of literature regarding sleep in cancer. This was a critical and systematic review of peer-reviewed, English-language, original articles published from 1980 through 15 October 2013, identified using electronic search engines, a set of key words, and prespecified inclusion and exclusion criteria. Information from 254 full-text, English-language articles was abstracted onto a paper checklist by one reviewer, with a second reviewer randomly verifying 50% (k = 99%). All abstracted data were entered into an electronic database, verified for accuracy, and analyzed using descriptive statistics and frequencies in SPSS (v.20) (North Castle, NY). Studies of sleep and cancer focus on specific types of symptoms of poor sleep, and there are no published prevalence studies that focus on underlying sleep disorders. Challenging the current paradigm of the way sleep is studied in cancer could produce better clinical screening tools for use in oncology clinics leading to better triaging of patients with sleep complaints to sleep specialists, and overall improvement in sleep quality.

Keywords: Cancer, review, sleep, sleep disorder, symptom assessment

Introduction

Sleep is vital to all human functioning and encompasses a complex set of physiological and behavioral processes; disruption in one or more of these processes can lead to many different types of symptoms of poor sleep that can occur singly or in combination. In cancer patients, disturbed sleep is rated the second most bothersome symptom based on cancer and treatment status ¹. Sleep problems are known to cause poor healing, increase chances of cancer recurrence, decreased cognitive functioning, decreased work productivity, increased safety issues, medication misuse and abuse, poor relationships, and increased health care costs ²^–²⁰.

Poor sleep is a known problem in cancer patients along the treatment trajectory from the point of diagnosis to end of life ²¹^,²². In the United States in 2013, estimates were that there are over 13.7 million people living as cancer survivors, another 1.66 million will be diagnosed with cancer, and more than 580,000 will die of cancer. Poor sleep is known to affect up to 75% of these individuals ²³^,²⁴. Because of the importance of sleep and the high prevalence of poor sleep in cancer, sleep-related research, and symptom management have been designated as research priorities by the Oncology Nursing Society ²⁵ and National Institute of Nursing Research ²⁶.

Poor sleep in cancer patients and survivors could be attributed to the presence of one or more underlying sleep disorders. Sleep disorders can be classified using two main classification systems, the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) ²⁷ or the International Classification of Sleep Disorders (ICSD) ²⁸, and they can directly impact health-related quality of life. Sleep disorders can occur singly or in combination and include insomnia, sleep-related breathing disorders, hypersomnia, circadian rhythm disorders, parasomnias, sleep-related movement disorders, isolated symptoms, and other nonspecified disorders ²⁹. Diagnosing specific sleep disorders usually requires a detailed and specialized evaluation, sometimes requiring overnight evaluation of objective measures of sleep. However, it has been reported that cancer patients often do not get referrals to sleep specialists when presenting with chronic sleep complaints. In a recent study of 78 patients with serious insomnia complaints, only four (5%) received a recommendation for formal follow-up or reassessment of the sleep problem ²⁰.

Details of specific sleep disorders should guide intervention(s) since each type of sleep disorder may require a different type of treatment. It is also pertinent to examine how treatment of such sleep disorders fits within the scope of practice for specialty clinics such as oncology. However, the extent to which sleep disorders have been studied in cancer is unclear, even though this information is vital to appropriate assessment and intervention. Therefore, the purpose of this systematic literature review was to evaluate if the prevalence of various types of sleep disorders could be ascertained from the current body of literature regarding sleep in cancer.

Methods

This was a critical and systematic review over a 2-year time frame of peer-reviewed, English-language, original articles published from 1980 through October 2013. We used PubMed, PsychINFO, CINAHL, and OVID search engines. Key words used for the search included; sleep, sleep disturbances, sleep problems, insomnia, circadian rhythm, restless leg syndrome, sleep apnea, narcolepsy, daytime dysfunction, daytime sleepiness, cancer, breast cancer. Breast cancer was specifically added as a search term to capture the large body of literature from this population on sleep. Limits were human, English language, and adults. Articles were included if: (1) sleep was identified as a primary outcome, a secondary outcome, or a covariable of interest; and (2) articles were focused on cancer diagnosis, treatment, survivorship, or end of life (not prevention). Excluded were review articles, case studies, and abstracts.

Article titles and abstracts were reviewed and screened for the following keywords; sleep, cancer, symptom cluster, menopausal symptoms, correlates of sleep, narcolepsy, circadian, restless leg syndrome, apnea, disturbance, and daytime dysfunction. If the title seemed to fit review criteria, the full-text article was pulled and read to determine relevance to the review. If the article was deemed relevant, information about the article was abstracted onto a paper checklist. Once the final article list was identified, references were checked against the available systematic reviews in the literature to ensure all relevant articles were captured. One reviewer completed data abstraction for all selected articles. A second reviewer randomly checked 50% of the articles for data abstraction accuracy. A kappa statistic was calculated and indicated good agreement between the raters (k = 99%), confirming the accuracy of the data abstraction. All abstracted data from the paper checklists were entered into an electronic database. All data entry was double checked for accuracy. Data were analyzed using SPSS (v.20) (North Castle, NY). Descriptive statistics and frequencies were obtained to synthesize the major points of this review.

Results

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) ³⁰ format was used as a guide to develop a search diagram showing the flow for the article retrieval process (Fig.1). A total of 2620 article titles were reviewed. This process resulted in identifying 339 full-text articles that were reviewed.

Of these, 254 articles met criteria to be included in this review. The 254 articles were mainly from the United States (n = 145, 57.5%) ³^–⁷^,¹⁰^–¹²^,¹⁴^,³¹^–¹⁶², United Kingdom/Europe (n = 43, 16.9%) ⁸^,¹⁶³^–¹⁸⁶, and Canada (n = 25, 9.8%) ¹⁶^,¹⁸⁷^–²²⁸. Very few were published during the 1980s (n = 4, 1.6%) ⁷⁸^,⁸²^,¹²⁸^,¹³⁵ or 1990s (n = 16, 7.1%) ¹⁰^,¹⁴^,⁴³^,⁴⁶^,⁵⁰^,⁵⁶^,⁹⁵^,¹⁰⁴^,¹¹⁰^,¹¹⁵^,¹²¹^,¹⁸⁹^,¹⁹⁹^,²⁰⁸^,²¹²^,²²⁹, with most published in 2000 or later (n = 233, 91.3%) ³^–⁸^,¹¹^,¹²^,¹⁵^,¹⁶^,³¹^–⁴²^,⁴⁴^–⁴⁹^,⁵¹^–⁵⁵^,⁵⁷^–⁷⁵^,⁷⁷^,⁷⁹^–⁸¹^,⁸³^–⁸⁵^,⁸⁷^–⁹⁴^,⁹⁶^–¹⁰³^,¹⁰⁵^–¹⁰⁹^,¹¹¹^–¹¹⁴^,¹¹⁶^–¹²⁰^,¹²²^–¹²⁷^,¹²⁹^–¹³⁴^,¹³⁶^–¹⁸⁸^,¹⁹⁰^–¹⁹⁸^,²⁰⁰^–²⁰⁷^,²⁰⁹^–²¹¹^,²¹³^–²²⁸^,²³⁰^–²⁶⁹. Quantitative descriptive studies were most common (n = 186, 73.6%), ³^–⁸^,¹¹^,¹²^,¹⁴^–¹⁶^,³¹^,³²^,³⁴^,³⁷^,³⁸^,⁴⁰^,⁴³^–⁴⁶^,⁴⁸^–⁵⁰^,⁵⁴^–⁶³^,⁶⁷^–⁷⁶^,⁷⁸^,⁸⁰^,⁸²^,⁸⁴^–¹⁰¹^,¹⁰³^–¹⁰⁸^,¹¹⁰^–¹¹⁶^,¹¹⁸^–¹²³^,¹²⁶^,¹²⁹^,¹³⁰^,¹³²^,¹³³^,¹³⁵^–¹⁴⁰^,¹⁴²^–¹⁴⁶^,¹⁴⁸^,¹⁵⁰^,¹⁵¹^,¹⁵⁴^,¹⁵⁵^,¹⁵⁸^–¹⁶⁰^,¹⁶²^,¹⁶³^,¹⁶⁵^,¹⁶⁸^–¹⁷¹^,¹⁷³^–¹⁷⁷^,¹⁸¹^–¹⁸⁵^,¹⁸⁸^,¹⁹¹^,¹⁹⁴^–¹⁹⁹^,²⁰²^–²⁰⁹^,²¹¹^,²¹³^–²¹⁵^,²¹⁷^–²²¹^,²²³^,²²⁴^,²²⁷^–²³³^,²³⁵^,²³⁷^,²³⁹^–²⁴³^,²⁴⁵^–²⁴⁹^,²⁵¹^–²⁵⁵^,²⁵⁷^,²⁵⁹^,²⁶⁰^,²⁶³^,²⁶⁵^–²⁶⁹ followed by intervention studies (n = 58, 22.8%), ³⁵^,³⁶^,³⁸^,³⁹^,⁴¹^,⁴²^,⁴⁷^,⁵¹^–⁵³^,⁶⁴^,⁶⁵^,⁷⁷^,⁸¹^,⁸³^,¹⁰²^,¹⁰⁹^,¹¹³^,¹¹⁷^,¹²⁴^,¹²⁷^,¹²⁸^,¹³¹^,¹³⁴^,¹⁴¹^,¹⁴⁷^,¹⁴⁹^,¹⁵³^,¹⁵⁶^,¹⁵⁷^,¹⁶¹^,¹⁶⁴^,¹⁶⁷^,¹⁷²^,¹⁷⁸^–¹⁸⁰^,¹⁸⁶^,¹⁸⁷^,¹⁸⁹^,¹⁹⁰^,¹⁹³^,²⁰¹^,²¹⁰^,²¹⁶^,²²²^,²²⁵^,²²⁶^,²³⁴^,²³⁸^,²⁴⁴^,²⁵⁰^,²⁵⁶^,²⁵⁸^,²⁶¹^,²⁶²^,²⁶⁴ qualitative studies (n = 7, 2.8%) ⁶⁶^,⁷⁹^,¹⁵²^,¹⁶⁶^,¹⁹²^,²⁰⁰^,²¹², and mixed-methods studies (n = 2, 0.8%) ¹⁰^,³³.

Description of studies

Study samples primarily included patients with a mix of different types of cancers (n = 104, 40.9%) ³^,⁴^,⁸^,¹⁰^,¹⁴^,³⁵^,³⁶^,⁴⁵^,⁴⁷^,⁴⁸^,⁵⁰^,⁵²^,⁵⁸^,⁶²^,⁶⁶^,⁶⁸^,⁶⁹^,⁷²^,⁷⁵^,⁷⁸^,⁸⁰^–⁸²^,⁸⁴^,⁸⁸^,⁸⁹^,⁹³^,⁹⁵^,⁹⁸^–¹⁰⁰^,¹⁰³^–¹⁰⁵^,¹¹¹^,¹¹³^,¹¹⁵^–¹¹⁷^,¹²⁰^–¹²²^,¹²⁷^–¹³⁰^,¹⁴³^,¹⁴⁵^,¹⁴⁹^,¹⁶¹^,¹⁶²^,¹⁶⁴^–¹⁷⁰^,¹⁷⁴^,¹⁸¹^,¹⁸²^,¹⁸⁴^,¹⁸⁷^,¹⁸⁹^–¹⁹²^,¹⁹⁴^–¹⁹⁶^,¹⁹⁸^,²⁰³^,²⁰⁶^,²⁰⁸^,²¹²^,²¹⁵^,²¹⁶^,²¹⁸^,²²¹^,²²³^,²²⁴^,²²⁷^–²²⁹^,²³¹^,²³²^,²³⁴^,²³⁶^,²³⁸^,²⁴⁰^–²⁴³^,²⁴⁵^,²⁴⁷^,²⁴⁸^,²⁵³^,²⁵⁴^,²⁵⁹^,²⁶¹^,²⁶⁴^,²⁶⁶^–²⁶⁸ or patients with breast cancer (n = 102, 40.2%), ⁵^–⁷^,¹¹^,¹²^,¹⁵^,¹⁶^,³¹^,³²^,³⁴^,³⁷^–⁴⁴^,⁴⁶^,⁴⁹^,⁵¹^,⁵⁵^–⁵⁷^,⁵⁹^,⁶¹^,⁶³^–⁶⁵^,⁷³^,⁷⁶^,⁷⁷^,⁷⁹^,⁸³^,⁸⁵^–⁸⁷^,⁹¹^,⁹²^,⁹⁴^,⁹⁶^,⁹⁷^,¹⁰¹^,¹⁰²^,¹⁰⁶^,¹⁰⁸^,¹¹²^,¹¹⁸^,¹¹⁹^,¹²³^–¹²⁶^,¹³¹^,¹³²^,¹³⁴^,¹³⁶^–¹⁴¹^,¹⁴⁸^,¹⁵¹^,¹⁵⁴^–¹⁶⁰^,¹⁶³^,¹⁷²^,¹⁷³^,¹⁷⁵^,¹⁷⁶^,¹⁷⁸^–¹⁸⁰^,¹⁸³^,¹⁸⁶^,¹⁸⁸^,¹⁹³^,²⁰⁰^–²⁰²^,²¹⁰^,²¹⁴^,²²⁰^,²²²^,²²⁵^,²²⁶^,²³⁰^,²³³^,²³⁹^,²⁴⁹^–²⁵¹^,²⁵⁶^,²⁶³^,²⁶⁵ with fewer studies focused on another single cancer diagnosis (n = 48, 18.9%) ³³^,³⁸^,⁵³^,⁵⁴^,⁶⁷^,⁷⁰^,⁷¹^,⁷⁴^,¹⁰⁷^,¹⁰⁹^,¹¹⁰^,¹¹⁴^,¹³³^,¹³⁵^,¹⁴²^,¹⁴⁴^,¹⁴⁶^,¹⁴⁷^,¹⁵⁰^,¹⁵²^,¹⁵³^,¹⁷¹^,¹⁸⁵^,¹⁹⁷^,¹⁹⁹^,²⁰⁴^,²⁰⁵^,²⁰⁷^,²⁰⁹^,²¹¹^,²¹³^,²¹⁷^,²¹⁹^,²³⁵^,²³⁷^,²⁴⁴^,²⁴⁶^,²⁵²^,²⁵⁵^,²⁵⁷^,²⁵⁸^,²⁶⁰^,²⁶²^,²⁶⁹. Of the latter, studies focusing on lung cancer were most common (n = 14) ⁷⁰^,⁷¹^,⁷⁴^,¹⁰⁹^,¹¹⁰^,¹³⁵^,¹⁴⁴^,¹⁵²^,¹⁹⁷^,²⁰⁴^,²⁰⁵^,²³⁵^,²⁴⁶^,²⁵⁷. The total number of participants with cancer appeared as high as 3343, although there was duplication where data were reported in more than one manuscript. The number of participants in the control groups (including cancer and noncancer) evaluated in studies was 1607. Only 90 studies (35%) ³^,⁷^,¹¹^,³⁴^–³⁶^,³⁸^,³⁹^,⁴³^,⁴⁶^,⁴⁸^,⁵⁰^–⁵³^,⁵⁸^,⁶³^–⁶⁵^,⁶⁹^–⁷¹^,⁷⁴^,⁷⁷^,⁷⁸^,⁸⁵^,⁹³^–⁹⁵^,¹⁰¹^,¹⁰²^,¹⁰⁶^,¹⁰⁹^,¹¹³^,¹¹⁵^,¹¹⁷^,¹²²^,¹²⁵^,¹²⁸^,¹²⁹^,¹³²^–¹³⁵^,¹³⁷^,¹⁴¹^,¹⁴⁵^–¹⁴⁷^,¹⁴⁹^,¹⁵³^–¹⁵⁷^,¹⁶¹^,¹⁶³^,¹⁷⁸^,¹⁷⁹^,¹⁸⁷^,¹⁸⁸^,¹⁹⁰^,¹⁹¹^,¹⁹³^,¹⁹⁴^,²⁰⁴^,²¹⁴^–²¹⁷^,²¹⁹^,²²⁴^,²²⁵^,²²⁹^,²³⁴^,²³⁶^,²³⁷^,²⁴⁰^,²⁴⁴^,²⁴⁵^,²⁴⁷^,²⁵⁰^,²⁵⁵^,²⁵⁶^,²⁵⁸^,²⁶¹^,²⁶²^,²⁶⁴ included a comparison group in the study design, with most comparison groups being subjects with cancer.

Sleep-specific characteristics of studies

Methodological characteristics of the 254 articles are shown in Table1. The time points for assessing sleep were varied but mainly focus on accessing sleep problems during and postcancer treatment. Most articles reviewed focused on sleep as a concurrently occurring or clustered variable with either fatigue or one or more other symptoms (59%). ³^,⁵^–⁷^,¹²^,¹⁴^–¹⁶^,³²^,³³^,³⁵^,³⁷^–⁴⁹^,⁵¹^–⁵⁴^,⁵⁶^–⁶²^,⁶⁷^–⁶⁹^,⁷¹^,⁷³^–⁷⁷^,⁷⁹^–⁸⁶^,⁸⁸^,⁸⁹^,⁹²^,⁹³^,⁹⁶^,⁹⁷^,¹⁰¹^,¹⁰²^,¹⁰⁴^–¹⁰⁸^,¹¹⁰^–¹¹⁴^,¹¹⁶^,¹¹⁸^,¹²²^,¹²⁴^–¹²⁷^,¹²⁹^–¹³¹^,¹³³^,¹³⁴^,¹³⁶^–¹⁵⁰^,¹⁵⁴^–¹⁶⁰^,¹⁶²^–¹⁶⁴^,¹⁶⁷^–¹⁷⁰^,¹⁷³^,¹⁷⁸^,¹⁷⁹^,¹⁸³^,¹⁸⁵^,¹⁸⁸^,¹⁹¹^,¹⁹³^,¹⁹⁵^,¹⁹⁸^,²⁰⁰^–²⁰³^,²⁰⁷^,²⁰⁸^,²¹²^,²¹⁴^–²¹⁶^,²¹⁸^,²²⁰^–²³⁰^,²³⁴^,²⁴¹^,²⁴³^–²⁴⁵^,²⁴⁷^,²⁴⁸^,²⁵⁰^–²⁵⁴^,²⁵⁶^–²⁵⁹^,²⁶¹^,²⁶³^–²⁶⁹.

Table 1.

Methodological characteristics of reviewed articles

Characteristic	N (%) n = 254
Type of cancer
Mixed	104 (40.9)
Breast	102 (40.2)
Other	48 (18.9)
Time point
Pretreatment	25 (9.8)
During treatment	76 (29.9)
Posttreatment	72 (28.3)
Palliative care	17 (6.7)
Mixed	49 (19.3)
Type of study design
Descriptive	187 (73.6)
Intervention	58 (22.8)
Qualitative	7 (2.8)
Mixed methods	2 (0.8)
Priority of sleep
Primary alone	83 (32.7)
Concurrent with fatigue	23 (9.1)
Concurrent with cluster	147 (57.9)
Sleep term defined
Yes	50 (19.7)
No	204 (80.3)
Formal classifications of sleep disorders used
Yes	26 (10.2)
No	228 (89.8)
Etiology of sleep problem provided
Yes	64 (25.2)
No	190 (74.8)
Subjective measure of sleep
PSQI	81 (31.9)
Single item from standardized form	46 (18.1)
No subjective measure	28 (11.0)
Other	99 (39.0)
Objective measure of sleep
Actigraphy	5 (20.9)
Polysomnography	16 (6.3)
None	185 (72.8)
Included biomarkers of sleep
Yes	18 (7.1)
No	236 (92.9)
Assessed medication use (prescription and over-the-counter)
Yes	64 (25.2)
No	190 (74.8)
Body mass index reported
Yes	44 (17.3)
No	213 (82.7)
Noncancer comorbidities reported
Yes	41 (16.1)
No	213 (83.9)
Discipline of author(s)
Nursing	62 (24.4)
Mixed	99 (39.0)
Medicine	48 (18.8)
Psychology	25 (9.8)
Other or not listed	20 (8.0)
Country of origin of authors
United States of America	146 (57.5)
United Kingdom/Europe	43 (16.9)
Canada	25 (9.8)
Year published
1982–1989	4 (1.6)
1990–1999	18 (7.1)
2000–2013	232 (91.3)
Discipline of author(s)
Nursing	62 (24.4)
Mixed	99 (39.0)
Medicine	48 (18.8)

Interventions studied	N (%)n = 54
Cognitive-behavioral therapy	23 (42.6)
Pharmacologic	6 (11.1)
Other	25 (46.3)

Open in a new tab

When selecting participants for studies, potentially important inclusion and exclusion criteria for sleep were rarely addressed. For example, only 19.7% (n = 50) ³⁵^–⁴¹^,⁴⁸^,⁴⁹^,¹⁶³^,¹⁸⁷^,²³³^–²³⁵^,⁶¹^,⁶³^,⁶⁹^,⁷⁷^,⁸⁷^,⁹⁰^,⁹¹^,⁹⁹^,¹⁰⁸^,¹⁰⁹^,¹¹⁵^,¹²²^,¹²⁹^,¹³⁶^,¹³⁸^,¹⁴⁰^,¹⁴¹^,¹⁵¹^,¹⁶⁰^,¹⁶¹^,¹⁷²^–¹⁷⁴^,¹⁷⁸^–¹⁸¹^,¹⁸⁹^,¹⁹²^,²⁰⁴^,²¹⁷^,²²¹^,²⁵⁵^,²⁶⁶ of the studies reviewed excluded for previous sleep disorder or current treatment of sleep disorders.

The majority of studies did not include a definition of sleep or sleep problems, did not classify sleep disorders, and did not discuss the etiology of the sleep problems studied. Only 26 (10.2%) ⁸^,³⁶^,⁴⁰^,⁵⁸^,⁶⁴^,⁶⁵^,⁷⁷^,⁹⁷^,⁹⁸^,¹⁰⁸^,¹⁰⁹^,¹¹⁵^,¹⁶¹^,¹⁷²^,¹⁷³^,¹⁷⁶^,¹⁷⁸^,¹⁷⁹^,¹⁸²^,¹⁹⁰^,¹⁹²^,²⁰⁹^,²¹⁰^,²¹⁶^,²³¹^,²⁴⁰ studies used a formal diagnostic classification system within the study design. Thirteen of these 26 studies used the DSM-IV (n = 13) ³⁶^,⁶⁵^,⁹⁷^,¹⁰⁸^,¹⁰⁹^,¹⁶¹^,¹⁷⁶^,¹⁹⁰^,¹⁹²^,²¹⁰^,²¹⁶^,²³¹^,²⁴⁰. The remaining 13 articles used a combination of the DSM and ICSD (n = 8), ICSD alone (n = 4), or a classification used by the American Society of Dentist Anesthesiologists (n = 1). Those using diagnostic classification systems used them as a mechanism to verify eligibility for studies specifically looking for primary insomnia. No other specific details from these studies were provided such as frequency of other possible sleep findings that could be used to establish some prevalence information.

In addition, sleep was primarily assessed using self-report and not objective measures. The most common standardized measure used was the Pittsburgh Sleep Quality Index (n = 81), a valid and reliable instrument. The most common approach was a single item or multiple items from a larger standardized or investigator-generated questionnaire. For objective measures, wrist actigraphy was the most common approach, with polysomnography only used in 16 studies. Wrist actigraphy is typically used more often due to the expense of polysomnography, which often requires an overnight stay in a hospital or clinic for evaluation.

Few studies reported assessing biomarkers such as ferritin, which plays a role in the etiology of restless leg syndrome. In addition, few studies reported concurrent medication use, particularly medications that could help or hinder sleep. Finally, few studies reported body mass index (important to diagnosing the potential for sleep apnea) or noncancer comorbidities that could hinder sleep. Potentially important exclusion criteria such as poor performance status, psychiatric illnesses, cognitive impairment, and anemia were also often not reported or not used.

Interventions were a part of only 33, or 13%, of the total studies reviewed. The most common interventions tested were formal or investigator-generated behavioral treatments for insomnia. Other interventions included mostly nonpharmacotherapy interventions such as acupuncture, yoga, relaxation, and exercise. Only five studies tested pharmacotherapy for treatment. The efficacy of these interventions for cancer patients has been assessed and can be found on the Oncology Nursing Society Putting Evidence into Practice website (www.ons.org).

Discussion

The major conclusion of this review is that the prevalence of overall particular types of sleep disorders in cancer cannot be ascertained using currently available literature. This is true across studies using mixed cancer samples and larger studies that focus specifically on populations of breast and lung cancer patients and survivors.

The main reason we cannot ascertain prevalence of specific sleep disorders relates to the conceptualization and operationalization of poor sleep. Our review indicates that studies have focused on measuring general symptoms of poor sleep rather than on the underlying sleep disorders. Symptoms of poor sleep include a decreased number of hours of sleep (sleep duration), increased number of minutes to fall asleep (sleep latency), nighttime awakenings (sleep disruptions), and inability to function fully during the day without naps (daytime dysfunction) ¹⁴^,²⁷⁰. These symptoms are consistent with insomnia and can occur singly or in combination, affecting overall sleep quality and daytime function ²⁷¹^–²⁷⁴. These symptoms help to define poor sleep but are common to more than one sleep disorder ²¹. In the reviewed literature, we found that the terminology for symptoms of poor sleep is often used interchangeably with that for specific sleep disorders which therefore are not fully assessed.

This imprecise conceptualization of sleep has led to narrowly focused interventions being diffusely targeted to symptoms, rather than focused and specific to one or more sleep disorders underlying those symptoms. Although some interventions for sleep in cancer have shown possible efficacy ²⁵, the majority of these studies are too targeted to undefined subtypes of insomnia and therefore are not generalizable to the many patients who may have other types of sleep disorders ¹¹³^,¹⁷⁸. This makes translating these interventions into oncology practice difficult.

To ascertain prevalence of the various types of disorders, we must change the current method for studying sleep in persons with cancer, which has focused on using single- or multi-item scales to assess and classify symptoms of poor sleep ¹⁷^,²¹^,²⁷⁵. A total of 33 different subjective sleep measures were used across studies, with little consistency among those measures although the Pittsburgh Sleep Quality Index, used in 32% of the studies, was the most common. These measures neglect the larger issue of assessing specific types of sleep disorders underlying symptoms (e.g., trouble falling asleep and staying asleep, nighttime disturbances) that are common to several different sleep disorders. Particular types of sleep disorders require different interventions, yet most intervention studies target undefined subtypes of insomnia as a single, underlying sleep disorder. This is problematic because there are 11 different subtypes of insomnia and not all are responsive to the same intervention ²⁸.

Based on reports from clinical practice, patients can experience more than one type of sleep disorder concurrently, which influences how sleep is treated. For example, one seminal study found that 40% of breast cancer survivors had symptoms suggestive of both insomnia (undeclared subtypes) and a sleep-related movement disorder (e.g., restless leg syndrome) ⁸. In addition, although sleep apnea has long been assumed to be relatively uncommon in women (<9%), one study of midlife women without cancer who reported symptoms of poor sleep found that 53% met criteria for sleep apnea ²⁷⁶. This supports the finding that postmenopausal women have sleep apnea at the same prevalence rate as men ²⁷⁷. These findings also suggest that the next logical step in sleep research for cancer patients is to correctly identify the prevalence of distinct types of sleep disorders in patients reporting symptoms of poor sleep so that appropriate clinical assessment tools and interventions can be developed and tested by oncology and general health-care providers. Perhaps this type of clinical assessment could be started in relation to one type of cancer such as in breast cancer patients and then translated to other cancer diagnoses or other chronic illnesses for testing.

Limitations of this review

Conclusions from this systematic review should be tempered in light of some limitations. First, our review focused on English-language articles, which may have excluded some important information about sleep disorders in cancer. Second, although every attempt was made to identify all pertinent articles, it is possible that some were missed, which also might have affected our conclusions.

Implications for practice

Sleep disorder prevalence data would be helpful for future intervention development. One place to begin is determining how symptoms are being addressed in the clinic visit. The role of oncology health practitioners in delineating complaints of sleep problems remains a challenge. With several formal practice guidelines available, the reality of clinic visits is that addressing symptoms is determined by a multitude of variables. During treatment there are sometimes other cancer-specific symptoms that are obvious contributing factors to acute sleep problems. For example, patients with end-stage lung cancer often have breathing problems that mimic sleep apnea or metastatic pain that is not controlled, and in this context pharmacological approaches may be appropriate. However, if such obvious problems are not present during survivorship it is unclear if oncology practitioners have the appropriate assessment tools to decide whether to make referrals to sleep specialists who could formally diagnose sleep disorders. Although practice guidelines can provide a global understanding of how to treat a patient with sleep complaints, future interventions for sleep need to involve educating about and implementing the use of short assessment tools for oncology patients and their providers as a basis for more effective treatments in the clinic setting and/or appropriate referrals for further testing. An assessment tool would need to be brief and target the common sleep disorders such as restless leg syndrome, sleep apnea, and possibly narcolepsy (although less frequently found in the general population). This tool would need to be sensitive enough to warrant appropriate referral to sleep medicine specialists for further diagnostic evaluation. Integrating into practice could be in the form of a screening tool that integrates into the electronic medical record to reflect current clinic practices. Future interventions should also be translatable to smaller community settings where specialized oncology clinics are not readily available.

For research there are several considerations moving forward. Revising common inclusion and exclusion criteria used in research studies is required to better reflect the complexity of sleep. Although specific inclusion and exclusion criteria for studies is largely dependent on the type of research question(s) being addressed, specific questions that identify possible symptoms of common sleep disorders for both descriptive and intervention research would better reflect the influence the fact that people tend to have more than one type of sleep problem. For behavioral intervention work this is especially crucial because having undiagnosed sleep disorders can have a negative impact on the efficacy findings of those studies. In addition, refining current measurements of sleep that better assist in detangling the common sleep complaint is required. Specifically, screening all research subjects using a brief screening form for sleep disorders would better identify the prevalence of specific sleep disorders across the cancer trajectory. Providing this type of information would better inform if different questionnaires were needed based on the type of cancer being studied based on the prevalence in that population.

Conclusion

Although the literature, especially in the past 10 years, has raised awareness that poor sleep is problematic throughout the cancer trajectory, the prevalence of particular types of sleep disorders in cancer remains unclear. This is likely due to the primary focus on studying symptoms of poor sleep and not characterizing the underlying sleep disorders in cancer patients and survivors. This review indicates that little is known about the prevalence of specific sleep disorders in cancer, which hampers the ability to fully understand (1) how to triage clinical assessments of sleep complaints by all levels and types of health-care practitioners that have contact with cancer patients and survivors and (2) how best to intervene for patients presenting in specialty clinics such as oncology with sleep complaints. Future studies should challenge the current research paradigm that focuses on describing and intervening narrowly on symptoms of poor sleep. Sleep screenings are needed that are tailored to facilitate better triage, referral for further assessment when appropriate, and more effective interventions that take into account the multiple types of sleep disorders.

Conflict of Interest

None declared.

References

Cleeland CS, Zhao F, Chang VT, Sloan JA, O'Mara AM, Gilman PB, et al. The symptom burden of cancer: evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer. 2013;119:4333–4340. doi: 10.1002/cncr.28376. [DOI] [PMC free article] [PubMed] [Google Scholar]
Ancoli-Israel S, Moore PJ. Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur. J. Cancer Care. 2001;10:245–255. doi: 10.1046/j.1365-2354.2001.00263.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Anderson KO, Getto CJ, Mendoza TR, Palmer SN, Wang XS, Reyes-Gibby CC, et al. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J. Pain Symptom Manage. 2003;25:307–318. doi: 10.1016/s0885-3924(02)00682-6. [DOI] [PubMed] [Google Scholar]
Beck SL, Schwartz AL, Towsley G, Dudley W. Barsevick A. Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J. Pain Symptom Manage. 2004;27:140–148. doi: 10.1016/j.jpainsymman.2003.12.002. [DOI] [PubMed] [Google Scholar]
Berger AM. Higginbotham P. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. Oncol. Nurs. Forum. 2000;27:1443–1448. [PubMed] [Google Scholar]
Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE. Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J. Clin. Oncol. 2000;18:743–753. doi: 10.1200/JCO.2000.18.4.743. [DOI] [PubMed] [Google Scholar]
Carpenter JS, Elam J, Ridner S, Carney P, Cherry G. Cucullu H. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol. Nurs. Forum. 2004;31:591–598. doi: 10.1188/04.onf.591-598. [DOI] [PubMed] [Google Scholar]
Davidson JR, MacLean AW, Brundage MD. Schulze K. Sleep disturbance in cancer patients. Soc. Sci. Med. 2002;54:1309–1321. doi: 10.1016/s0277-9536(01)00043-0. [DOI] [PubMed] [Google Scholar]
Dow KH, Ferrell BR, Leigh S, Ly J. Gulasekaram P. An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Res. Treat. 1996;39:261–273. doi: 10.1007/BF01806154. [DOI] [PubMed] [Google Scholar]
Engstrom CA, Strohl RA, Rose L, Lewandowski L. Stefanek ME. Sleep alterations in cancer patients. Cancer Nurs. 1999;22:143–148. doi: 10.1097/00002820-199904000-00006. [DOI] [PubMed] [Google Scholar]
Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S. Durrence HH. Sleep and quality of life in breast cancer patients. J. Pain Symptom Manage. 2002;24:471–480. doi: 10.1016/s0885-3924(02)00500-6. [DOI] [PubMed] [Google Scholar]
Koopman C, Nouriani B, Erickson V, Anupindi R, Butler LD, Bachmann MH, et al. Sleep disturbances in women with metastatic breast cancer. Breast J. 2002;8:362–370. doi: 10.1046/j.1524-4741.2002.08606.x. [DOI] [PubMed] [Google Scholar]
Lee K, Cho M, Miaskowski C. Dodd M. Impaired sleep and rhythms in persons with cancer. Sleep Med. Rev. 2004;8:199–212. doi: 10.1016/j.smrv.2003.10.001. [DOI] [PubMed] [Google Scholar]
Miaskowski C. Lee KA. Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J. Pain Symptom Manage. 1999;17:320–332. doi: 10.1016/s0885-3924(99)00008-1. [DOI] [PubMed] [Google Scholar]
Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T, et al. Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support. Care Cancer. 2000;8:215–222. doi: 10.1007/s005200050288. [DOI] [PubMed] [Google Scholar]
Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Matteson S, Rakita D, et al. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support. Care Cancer. 2002;10:329–336. doi: 10.1007/s00520-001-0317-0. [DOI] [PubMed] [Google Scholar]
Savard J. Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J. Clin. Oncol. 2001;19:895–908. doi: 10.1200/JCO.2001.19.3.895. [DOI] [PubMed] [Google Scholar]
Deimling GT, Kahana B, Bowman KF. Schaefer ML. Cancer survivorship and psychological distress in later life. Psychooncology. 2002;11:479–494. doi: 10.1002/pon.614. [DOI] [PubMed] [Google Scholar]
Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE. Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J. Natl. Cancer Inst. 2002;94:39–49. doi: 10.1093/jnci/94.1.39. [DOI] [PubMed] [Google Scholar]
Siefert ML, Hong F, Valcarce B. Berry DL. Patient and clinician communication of self-reported insomnia during ambulatory cancer care clinic visits. Cancer Nurs. 2013;37:E51–E59. doi: 10.1097/NCC.0b013e318283a7bc. [DOI] [PMC free article] [PubMed] [Google Scholar]
Berger AM, Parker KP, Young-McCaughan S, Mallory GA, Barsevick AM, Beck SL, et al. Sleep wake disturbances in people with cancer and their caregivers: state of the science. Oncol. Nurs. Forum. 2005;32:E98–E126. doi: 10.1188/05.ONF.E98-E126. [DOI] [PubMed] [Google Scholar]
Vena C, Parker K, Cunningham M, Clark J. McMillan S. Continuing education: sleep-wake disturbances in people with cancer part I: an overview of sleep, sleep regulation, and effects of disease and treatment. Oncol. Nurs. Forum. 2004;31:735–746. doi: 10.1188/04.ONF.735-746. [DOI] [PubMed] [Google Scholar]
Institute NC. SEER Stat Fact Sheet: all cancer sites. Available at: http://seer.cancer.gov/statfacts/html/all.html (accessed 10 January 2014)
Institute NC. Survivorship-related statistics and graphs. Available at: http://cancercontrol.cancer.gov/ocs/prevalence/ (accessed 10 January 2014)
Oncology Nursing Society. Onzrcology nursing society 2009-2013 research Agenda. Available at: www.ons.org (accessed 21 January 2014)
Department of Health and Human Services. Bethesda: National Institutes of Health; 2011. Bringing science to life-NINR strategic plan. [Google Scholar]
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994. [Google Scholar]
American Academy of Sleep Medicine. The international classification of sleep disorders: diagnostic and coding manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005. [Google Scholar]
Golbin AZ, Kravitz HM, Keith LG. Barkin RL. Sleep psychiatry. New York, NY: Taylor & Francis; 2004. [Google Scholar]
Moher D, Liberati A, Tetzlaff J. Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J. Clin. Epidemiol. 2009;62:1006–1012. doi: 10.1016/j.jclinepi.2009.06.005. [DOI] [PubMed] [Google Scholar]
Alfano CM, Lichstein KL, Vander Wal GS, Smith AW, Reeve BB, McTiernan A, et al. Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life. Breast Cancer Res. Treat. 2011;130:243–254. doi: 10.1007/s10549-011-1530-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR, et al. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support. Care Cancer. 2006;14:201–209. doi: 10.1007/s00520-005-0861-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
Baldwin CM, Grant M, Wendel C, Hornbrook MC, Herrinton LJ, McMullen C, et al. Gender differences in sleep disruption and fatigue on quality of life among persons with ostomies. J. Clin. Sleep Med. 2009;5:335–343. [PMC free article] [PubMed] [Google Scholar]
Bardwell WA, Profant J, Casden DR, Dimsdale JE, Ancoli-Israel S, Natarajan L, et al. The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psychooncology. 2008;17:9–18. doi: 10.1002/pon.1192. [DOI] [PMC free article] [PubMed] [Google Scholar]
Barsevick A, Beck SL, Dudley WN, Wong B, Berger AM, Whitmer K, et al. Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy. J. Pain Symptom Manage. 2010;40:200–216. doi: 10.1016/j.jpainsymman.2009.12.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
Barton DL, Atherton PJ, Bauer BA, Moore DF, Jr, Mattar BI, Lavasseur BI, et al. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5) J. Support. Oncol. 2011;9:24–31. doi: 10.1016/j.suponc.2010.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
Berger AM, Farr LA, Kuhn BR, Fischer P. Agrawal S. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J. Pain Symptom Manage. 2007;33:398–409. doi: 10.1016/j.jpainsymman.2006.09.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
Berger AM, Kuhn BR, Farr LA, Lynch JC, Agrawal S, Chamberlain J, et al. Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue. Psychooncology. 2009;18:634–646. doi: 10.1002/pon.1438. [DOI] [PubMed] [Google Scholar]
Berger AM, Kuhn BR, Farr LA, Von Essen SG, Chamberlain J, Lynch JC, et al. One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue. J. Clin. Oncol. 2009;27:6033–6040. doi: 10.1200/JCO.2008.20.8306. [DOI] [PMC free article] [PubMed] [Google Scholar]
Berger AM, Treat Marunda HA. Agrawal S. Influence of menopausal status on sleep and hot flashes throughout breast cancer adjuvant chemotherapy. J. Obstet. Gynecol. Neonatal. Nurs. 2009;38:353–366. doi: 10.1111/j.1552-6909.2009.01030.x. [DOI] [PubMed] [Google Scholar]
Berger AM, VonEssen S, Khun BR, Piper BF, Farr L, Agrawal S, et al. Feasibility of a sleep intervention during adjuvant breast cancer chemotherapy. Oncol. Nurs. Forum. 2002;29:1431–1441. doi: 10.1188/02.ONF.1431-1441. [DOI] [PubMed] [Google Scholar]
Berger AM, VonEssen S, Kuhn BR, Piper BF, Agrawal S, Lynch JC, et al. Adherence, sleep, and fatigue outcomes after adjuvant breast cancer chemotherapy: results of a feasibility intervention study. Oncol. Nurs. Forum. 2003;30:513–522. doi: 10.1188/03.ONF.513-522. [DOI] [PubMed] [Google Scholar]
Berger AM. Farr L. The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncol. Nurs. Forum. 1999;26:1663–1671. [PubMed] [Google Scholar]
Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC. Cole SW. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J. Clin. Oncol. 2011;29:3517–3522. doi: 10.1200/JCO.2011.36.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
Breen SJ, Baravelli CM, Schofield PE, Jefford M, Yates PM. Aranda SK. Is symptom burden a predictor of anxiety and depression in patients with cancer about to commence chemotherapy? Med. J. Aust. 2009;190(Suppl. 7):S99–S104. doi: 10.5694/j.1326-5377.2009.tb02480.x. [DOI] [PubMed] [Google Scholar]
Broeckel JA, Jacobsen PB, Horton J, Balducci L. Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J. Clin. Oncol. 1998;16:1689–1696. doi: 10.1200/JCO.1998.16.5.1689. [DOI] [PubMed] [Google Scholar]
Bruera E, Strasser F, Shen L, Palmer JL, Willey J, Driver LC, et al. The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study. J. Pain Symptom Manage. 2003;26:1049–1054. doi: 10.1016/s0885-3924(03)00332-4. [DOI] [PubMed] [Google Scholar]
Buffum D, Koetters T, Cho M, Macera L, Paul SM, West C, et al. The effects of pain, gender, and age on sleep/wake and circadian rhythm parameters in oncology patients at the initiation of radiation therapy. J. Pain. 2011;12:390–400. doi: 10.1016/j.jpain.2010.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
Byar KL, Berger AM, Bakken SL. Cetak MA. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol. Nurs. Forum. 2006;33:E18–E26. doi: 10.1188/06.ONF.E18-E26. [DOI] [PubMed] [Google Scholar]
Carpenter JS. Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J. Psychosom. Res. 1998;45:5–13. doi: 10.1016/s0022-3999(97)00298-5. [DOI] [PubMed] [Google Scholar]
Carson JW, Carson KM, Porter LS, Keefe FJ. Seewaldt VL. Yoga of Awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial. Support. Care Cancer. 2009;17:1301–1309. doi: 10.1007/s00520-009-0587-5. [DOI] [PubMed] [Google Scholar]
Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, et al. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J. Clin. Oncol. 2011;29:994–1000. doi: 10.1200/JCO.2010.29.8315. [DOI] [PMC free article] [PubMed] [Google Scholar]
Cohen L, Warneke C, Fouladi RT, Rodriguez MA. Chaoul-Reich A. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer. 2004;100:2253–2260. doi: 10.1002/cncr.20236. [DOI] [PubMed] [Google Scholar]
Coleman EA, Goodwin JA, Coon SK, Richards K, Enderlin C, Kennedy R, et al. Fatigue, sleep, pain, mood, and performance status in patients with multiple myeloma. Cancer Nurs. 2011;34:219–227. doi: 10.1097/NCC.0b013e3181f9904d. [DOI] [PMC free article] [PubMed] [Google Scholar]
Costantini C, Ale-Ali A. Helsten T. Sleep aid prescribing practices during neoadjuvant or adjuvant chemotherapy for breast cancer. J. Palliat. Med. 2011;14:563–566. doi: 10.1089/jpm.2010.0465. [DOI] [PubMed] [Google Scholar]
Couzi RJ, Helzlsouer KJ. Fetting JH. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J. Clin. Oncol. 1995;13:2737–2744. doi: 10.1200/JCO.1995.13.11.2737. [DOI] [PubMed] [Google Scholar]
Crandall C, Petersen L, Ganz PA. Greendale GA. Association of breast cancer and its therapy with menopause-related symptoms. Menopause. 2004;11:519–530. doi: 10.1097/01.gme.0000117061.40493.ab. [DOI] [PubMed] [Google Scholar]
Delgado-Guay M, Yennurajalingam S, Parsons H, Palmer JL. Bruera E. Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer. J. Pain Symptom Manage. 2011;41:819–827. doi: 10.1016/j.jpainsymman.2010.07.015. [DOI] [PubMed] [Google Scholar]
Dirksen SR, Belyea MJ. Epstein DR. Fatigue-based subgroups of breast cancer survivors with insomnia. Cancer Nurs. 2009;32:404–411. doi: 10.1097/NCC.0b013e3181a5d05e. [DOI] [PMC free article] [PubMed] [Google Scholar]
Dirksen SR, Epstein DR. Hoyt MA. Insomnia, depression, and distress among outpatients with prostate cancer. Appl. Nurs. Res. 2009;22:154–158. doi: 10.1016/j.apnr.2007.09.001. [DOI] [PubMed] [Google Scholar]
Dodd MJ, Cho MH, Cooper BA. Miaskowski C. The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur. J. Oncol. Nurs. 2010;14:101–110. doi: 10.1016/j.ejon.2009.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
Dodd MJ, Miaskowski C. Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol. Nurs. Forum. 2001;28:465–470. [PubMed] [Google Scholar]
Enderlin CA, Coleman EA, Cole C, Richards KC, Kennedy RL, Goodwin JA, et al. Subjective sleep quality, objective sleep characteristics, insomnia symptom severity, and daytime sleepiness in women aged 50 and older with nonmetastatic breast cancer. Oncol. Nurs. Forum. 2011;38:E314–E325. doi: 10.1188/11.ONF.E314-E325. [DOI] [PubMed] [Google Scholar]
Epstein DR. Dirksen SR. Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors. Oncol. Nurs. Forum. 2007;34:E51–E59. doi: 10.1188/07.ONF.E51-E59. [DOI] [PubMed] [Google Scholar]
Fiorentino L, McQuaid JR, Liu L, Natarajan L, He F, Cornejo M, et al. Individual cognitive behavioral therapy for insomnia in breast cancer survivors: a randomized controlled crossover pilot study. Nat. Sci. Sleep. 2010;2:1–8. doi: 10.2147/NSS.S8004. [DOI] [PMC free article] [PubMed] [Google Scholar]
Flynn KE, Shelby RA, Mitchell SA, Fawzy MR, Hardy NC, Husain AM, et al. Sleep-wake functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)) Psychooncology. 2010;19:1086–1093. doi: 10.1002/pon.1664. [DOI] [PMC free article] [PubMed] [Google Scholar]
Fox SW, Lyon D. Farace E. Symptom clusters in patients with high-grade glioma. J. Nurs. Scholarsh. 2007;39:61–67. doi: 10.1111/j.1547-5069.2007.00144.x. [DOI] [PubMed] [Google Scholar]
Francoeur RB. The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation. J. Pain Symptom Manage. 2005;29:130–155. doi: 10.1016/j.jpainsymman.2004.04.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
Garrett K, Dhruva A, Koetters T, West C, Paul SM, Dunn LB, et al. Differences in sleep disturbance and fatigue between patients with breast and prostate cancer at the initiation of radiation therapy. J. Pain Symptom Manage. 2011;42:239–250. doi: 10.1016/j.jpainsymman.2010.11.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
Gooneratne NS, Dean GE, Rogers AE, Nkwuo JE, Coyne JC. Kaiser LR. Sleep and quality of life in long-term lung cancer survivors. Lung Cancer. 2007;58:403–410. doi: 10.1016/j.lungcan.2007.07.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
Grutsch JF, Ferrans C, Wood PA, Du-Quiton J, Quiton DF, Reynolds JL, et al. The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. BMC Cancer. 2011;11:1–13. doi: 10.1186/1471-2407-11-193. [DOI] [PMC free article] [PubMed] [Google Scholar]
Hanisch LJ, Gooneratne NS, Soin K, Gehrman PR, Vaughn DJ. Coyne JC. Sleep and daily functioning during androgen deprivation therapy for prostate cancer. Eur. J. Cancer Care (Engl.) 2011;20:549–554. doi: 10.1111/j.1365-2354.2010.01226.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Hickey M, Emery LI, Gregson J, Doherty DA. Saunders CM. The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care. Menopause. 2010;17:727–733. doi: 10.1097/gme.0b013e3181d672f6. [DOI] [PubMed] [Google Scholar]
Hoffman AJ, Given BA, von Eye A, Gift AG. Given CW. Relationships among pain, fatigue, insomnia, and gender in persons with lung cancer. Oncol. Nurs. Forum. 2007;34:785–792. doi: 10.1188/07.ONF.785-792. [DOI] [PubMed] [Google Scholar]
Hoyt MA, Thomas KS, Epstein DR. Dirksen SR. Coping style and sleep quality in men with cancer. Ann. Behav. Med. 2009;37:88–93. doi: 10.1007/s12160-009-9079-6. [DOI] [PubMed] [Google Scholar]
Janz NK, Mujahid M, Chung LK, Lantz PM, Hawley ST, Morrow M, et al. Symptom experience and quality of life of women following breast cancer treatment. J. Womens Health. 2007;16:1348–1361. doi: 10.1089/jwh.2006.0255. [DOI] [PubMed] [Google Scholar]
Joffe H, Partridge A, Giobbie-Hurder A, Li X, Habin K, Goss P, et al. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. Menopause. 2010;17:908–916. doi: 10.1097/gme.0b013e3181dbee1b. [DOI] [PubMed] [Google Scholar]
Kaye J, Kaye K. Madow L. Sleep patterns in patients with cancer and patients with cardiac disease. J. Psychol. 1983;114(1st Half):107–113. doi: 10.1080/00223980.1983.9915403. [DOI] [PubMed] [Google Scholar]
Knobf MT. The menopausal symptom experience in young mid-life women with breast cancer. Cancer Nurs. 2001;24:201–210. [PubMed] [Google Scholar]
Kozachik SL. Bandeen-Roche K. Predictors of patterns of pain, fatigue, and insomnia during the first year after a cancer diagnosis in the elderly. Cancer Nurs. 2008;31:334–344. doi: 10.1097/01.NCC.0000305769.27227.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
Kwekkeboom KL, Abbott-Anderson K. Wanta B. Feasibility of a patient-controlled cognitive-behavioral intervention for pain, fatigue, and sleep disturbance in cancer. Oncol. Nurs. Forum. 2010;37:E151–E159. doi: 10.1188/10.ONF.E151-E159. [DOI] [PMC free article] [PubMed] [Google Scholar]
Lamb MA. The sleeping patterns of patients with malignant and nonmalignant diseases. Cancer Nurs. 1982;5:389–396. [PubMed] [Google Scholar]
Lipov EG, Joshi JR, Sanders S, Wilcox K, Lipov S, Xie H, et al. Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study. Lancet Oncol. 2008;9:523–532. doi: 10.1016/S1470-2045(08)70131-1. [DOI] [PubMed] [Google Scholar]
Lis CG, Gupta D. Grutsch JF. The relationship between insomnia and patient satisfaction with quality of life in cancer. Support. Care Cancer. 2008;16:261–266. doi: 10.1007/s00520-007-0314-z. [DOI] [PubMed] [Google Scholar]
Liu L, Fiorentino L, Natarajan L, Parker BA, Mills PJ, Sadler GR, et al. Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psychooncology. 2009;18:187–194. doi: 10.1002/pon.1412. [DOI] [PMC free article] [PubMed] [Google Scholar]
Matthews EE, Schmiege SJ, Cook PF. Sousa KH. Breast cancer and symptom clusters during radiotherapy. Cancer Nurs. 2012;35:E1–E11. doi: 10.1097/NCC.0b013e3182277222. [DOI] [PubMed] [Google Scholar]
McChargue DE, Sankaranarayanan J, Visovsky CG, Matthews EE, Highland KB. Berger AM. Predictors of adherence to a behavioral therapy sleep intervention during breast cancer chemotherapy. Support. Care Cancer. 2012;20:245–252. doi: 10.1007/s00520-010-1060-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
McMillan SC, Tittle M, Hagan S. Laughlin J. Management of pain and pain-related symptoms in hospitalized veterans with cancer. Cancer Nurs. 2000;23:327–336. doi: 10.1097/00002820-200010000-00001. [DOI] [PubMed] [Google Scholar]
McMillan SC, Tofthagen C. Morgan MA. Relationships among pain, sleep disturbances, and depressive symptoms in outpatients from a comprehensive cancer center. Oncol. Nurs. Forum. 2008;35:603–611. doi: 10.1188/08.ONF.603-611. [DOI] [PubMed] [Google Scholar]
Miaskowski C, Paul SM, Cooper BA, Lee K, Dodd M, West C, et al. Predictors of the trajectories of self-reported sleep disturbance in men with prostate cancer during and following radiation therapy. Sleep. 2011;34:171–179. doi: 10.1093/sleep/34.2.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
Moore TA, Berger AM. Dizona P. Sleep aid use during and following breast cancer adjuvant chemotherapy. Psychooncology. 2011;20:321–325. doi: 10.1002/pon.1756. [DOI] [PMC free article] [PubMed] [Google Scholar]
Mosher CE. Duhamel KN. An examination of distress, sleep, and fatigue in metastatic breast cancer patients. Psychooncology. 2012;21:100–107. doi: 10.1002/pon.1873. [DOI] [PMC free article] [PubMed] [Google Scholar]
Mulrooney DA, Ness KK, Neglia JP, Whitton JA, Green DM, Zeltzer LK, et al. Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS) Sleep. 2008;31:271–281. doi: 10.1093/sleep/31.2.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
Otte JL, Carpenter JS, Russell KM, Bigatti S. Champion VL. Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. J. Pain Symptom Manage. 2010;39:535–547. doi: 10.1016/j.jpainsymman.2009.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
Owen DC, Parker KP. McGuire DB. Comparison of subjective sleep quality in patients with cancer and healthy subjects. Oncol. Nurs. Forum. 1999;26:1649–1651. [PubMed] [Google Scholar]
Palesh O, Zeitzer JM, Conrad A, Giese-Davis J, Mustian KM, Popek V, et al. Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer. J. Clin. Sleep Med. 2008;4:441–449. [PMC free article] [PubMed] [Google Scholar]
Palesh OG, Collie K, Batiuchok D, Tilston J, Koopman C, Perlis ML, et al. A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol. Psychol. 2007;75:37–44. doi: 10.1016/j.biopsycho.2006.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J. Clin. Oncol. 2010;28:292–298. doi: 10.1200/JCO.2009.22.5011. [DOI] [PMC free article] [PubMed] [Google Scholar]
Parker KP, Bliwise DL, Ribeiro M, Jain SR, Vena CI, Kohles-Baker MK, et al. Sleep/wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J. Clin. Oncol. 2008;26:2464–2472. doi: 10.1200/JCO.2007.12.2135. [DOI] [PubMed] [Google Scholar]
Passik SD, Whitcomb LA, Kirsh KL. Theobald DE. An unsuccessful attempt to develop a single-item screen for insomnia in cancer patients. J. Pain Symptom Manage. 2003;25:284–287. doi: 10.1016/s0885-3924(02)00692-9. [DOI] [PubMed] [Google Scholar]
Payne J, Piper B, Rabinowitz I. Zimmerman B. Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study. Oncol. Nurs. Forum. 2006;33:775–783. doi: 10.1188/06.ONF.775-783. [DOI] [PubMed] [Google Scholar]
Payne JK, Held J, Thorpe J. Shaw H. Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. Oncol. Nurs. Forum. 2008;35:635–642. doi: 10.1188/08.ONF.635-642. [DOI] [PubMed] [Google Scholar]
Phillips KM, Jim HS, Donovan KA, Pinder-Schenck MC. Jacobsen PB. Characteristics and correlates of sleep disturbances in cancer patients. Support. Care Cancer. 2012;20:357–365. doi: 10.1007/s00520-011-1106-z. [DOI] [PubMed] [Google Scholar]
Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Coyle N, et al. Symptom prevalence, characteristics and distress in a cancer population. Qual. Life Res. 1994;3:183–189. doi: 10.1007/BF00435383. [DOI] [PubMed] [Google Scholar]
Redeker NS, Lev EL. Ruggiero J. Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch. Inq. Nurs. Pract. 2000;14:275–290. discussion 91-8. [PubMed] [Google Scholar]
Rissling MB, Liu L, Natarajan L, He F. Ancoli-Israel S. Relationship of menopausal status and climacteric symptoms to sleep in women undergoing chemotherapy. Support. Care Cancer. 2011;19:1107–1115. doi: 10.1007/s00520-010-0914-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Rogers LQ, Courneya KS, Robbins KT, Rao K, Malone J, Seiz A, et al. Factors associated with fatigue, sleep, and cognitive function among patients with head and neck cancer. Head Neck. 2008;30:1310–1317. doi: 10.1002/hed.20873. [DOI] [PubMed] [Google Scholar]
Rumble ME, Keefe FJ, Edinger JD, Affleck G, Marcom PK. Shaw HS. Contribution of cancer symptoms, dysfunctional sleep related thoughts, and sleep inhibitory behaviors to the insomnia process in breast cancer survivors: a daily process analysis. Sleep. 2010;33:1501–1509. doi: 10.1093/sleep/33.11.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
Rumble ME, Keefe FJ, Edinger JD, Porter LS. Garst JL. A pilot study investigating the utility of the cognitive-behavioral model of insomnia in early-stage lung cancer patients. J. Pain Symptom Manage. 2005;30:160–169. doi: 10.1016/j.jpainsymman.2005.02.013. [DOI] [PubMed] [Google Scholar]
Sarna L. Correlates of symptom distress in women with lung cancer. Cancer Pract. 1993;1:21–28. [PubMed] [Google Scholar]
Schlairet MC. Needs of older cancer survivors in a community cancer care setting. J. Gerontol. Nurs. 2011;37:36–41. doi: 10.3928/00989134-20100730-05. [DOI] [PubMed] [Google Scholar]
Schultz PN, Klein MJ, Beck ML, Stava C. Sellin RV. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors. J. Clin. Nurs. 2005;14:204–211. doi: 10.1111/j.1365-2702.2004.01030.x. [DOI] [PubMed] [Google Scholar]
Sherwood P, Given BA, Given CW, Champion VL, Doorenbos AZ, Azzouz F, et al. A cognitive behavioral intervention for symptom management in patients with advanced cancer. Oncol. Nurs. Forum. 2005;32:1190–1198. doi: 10.1188/05.ONF.1190-1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
Shuman AG, Duffy SA, Ronis DL, Garetz SL, McLean SA, Fowler KE, et al. Predictors of poor sleep quality among head and neck cancer patients. Laryngoscope. 2010;120:1166–1172. doi: 10.1002/lary.20924. [DOI] [PMC free article] [PubMed] [Google Scholar]
Silberfarb PM, Hauri PJ, Oxman TE. Schnurr P. Assessment of sleep in patients with lung cancer and breast cancer. J. Clin. Oncol. 1993;11:997–1004. doi: 10.1200/JCO.1993.11.5.997. [DOI] [PubMed] [Google Scholar]
Snyder CF, Garrett-Mayer E, Brahmer JR, Carducci MA, Pili R, Stearns V, et al. Symptoms, supportive care needs, and function in cancer patients: how are they related? Qual. Life Res. 2008;17:665–677. doi: 10.1007/s11136-008-9331-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
Sprod LK, Palesh OG, Janelsins MC, Peppone LJ, Heckler CE, Adams MJ, et al. Exercise, sleep quality, and mediators of sleep in breast and prostate cancer patients receiving radiation therapy. Community Oncol. 2010;7:463–471. doi: 10.1016/s1548-5315(11)70427-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
Tatrow K, Montgomery GH, Avellino M. Bovbjerg DH. Activity and sleep contribute to levels of anticipatory distress in breast surgery patients. Behav. Med. 2004;30:85–91. doi: 10.3200/BMED.30.2.85-94. [DOI] [PubMed] [Google Scholar]
Taylor TR, Huntley ED, Makambi K, Sween J, Adams-Campbell LL, Frederick W, et al. Understanding sleep disturbances in African-American breast cancer survivors: a pilot study. Psychooncology. 2012;21:896–902. doi: 10.1002/pon.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
Thomas KS, Bower J, Hoyt MA. Sepah S. Disrupted sleep in breast and prostate cancer patients undergoing radiation therapy: the role of coping processes. Psychooncology. 2010;19:767–776. doi: 10.1002/pon.1639. [DOI] [PMC free article] [PubMed] [Google Scholar]
Sheely LC. Sleep disturbances in hospitalized patients with cancer. Oncol. Nurs. Forum. 1996;23:109–111. [PubMed] [Google Scholar]
Van Onselen C, Dunn LB, Lee K, Dodd M, Koetters T, West C, et al. Relationship between mood disturbance and sleep quality in oncology outpatients at the initiation of radiation therapy. Eur. J. Oncol. Nurs. 2010;14:373–379. doi: 10.1016/j.ejon.2009.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
Vargas S, Wohlgemuth WK, Antoni MH, Lechner SC, Holley HA. Carver CS. Sleep dysfunction and psychosocial adaptation among women undergoing treatment for non-metastatic breast cancer. Psychooncology. 2010;19:669–673. doi: 10.1002/pon.1603. [DOI] [PMC free article] [PubMed] [Google Scholar]
Weitzner MA, Moncello J, Jacobsen PB. Minton S. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J. Pain Symptom Manage. 2002;23:337–345. doi: 10.1016/s0885-3924(02)00379-2. [DOI] [PubMed] [Google Scholar]
Williams SA. Schreier AM. The role of education in managing fatigue, anxiety, and sleep disorders in women undergoing chemotherapy for breast cancer. Appl. Nurs. Res. 2005;18:138–147. doi: 10.1016/j.apnr.2004.08.005. [DOI] [PubMed] [Google Scholar]
Wright CE, Bovbjerg DH, Montgomery GH, Weltz C, Goldfarb A, Pace B, et al. Disrupted sleep the night before breast surgery is associated with increased postoperative pain. J. Pain Symptom Manage. 2009;37:352–362. doi: 10.1016/j.jpainsymman.2008.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
Young-McCaughan S, Mays MZ, Arzola SM, Yoder LH, Dramiga SA, Leclerc KM, et al. Research and commentary: change in exercise tolerance, activity and sleep patterns, and quality of life in patients with cancer participating in a structured exercise program. Oncol. Nurs. Forum. 2003;30:441–454. doi: 10.1188/03.ONF.441-454. [DOI] [PubMed] [Google Scholar]
Cannici J, Malcolm R. Peek LA. Treatment of insomnia in cancer patients using muscle relaxation training. J. Behav. Ther. Exp. Psychiatry. 1983;14:251–256. doi: 10.1016/0005-7916(83)90056-3. [DOI] [PubMed] [Google Scholar]
Merriman JD, Dodd M, Lee K, Paul SM, Cooper BA, Aouizerat BE, et al. Differences in self-reported attentional fatigue between patients with breast and prostate cancer at the initiation of radiation therapy. Cancer Nurs. 2011;34:345–353. doi: 10.1097/NCC.0b013e318202520a. [DOI] [PMC free article] [PubMed] [Google Scholar]
Miaskowski C, Lee K, Dunn L, Dodd M, Aouizerat BE, West C, et al. Sleep-wake circadian activity rhythm parameters and fatigue in oncology patients before the initiation of radiation therapy. Cancer Nurs. 2011;34:255–268. doi: 10.1097/NCC.0b013e3181f65d9b. [DOI] [PMC free article] [PubMed] [Google Scholar]
Otte JL, Carpenter JS, Zhong X. Johnstone PA. Feasibility study of acupuncture for reducing sleep disturbances and hot flashes in postmenopausal breast cancer survivors. Clin. Nurse Spec. 2011;25:228–236. doi: 10.1097/NUR.0b013e318229950b. [DOI] [PMC free article] [PubMed] [Google Scholar]
Otte JL, Payne JK. Carpenter JS. Nighttime variability in wrist actigraphy. J. Nurs. Meas. 2011;19:105–114. doi: 10.1891/1061-3749.19.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
Sandadi S, Frasure HE, Broderick MJ, Waggoner SE, Miller JA. von Gruenigen VE. The effect of sleep disturbance on quality of life in women with ovarian cancer. Gynecol. Oncol. 2011;123:351–355. doi: 10.1016/j.ygyno.2011.07.028. [DOI] [PubMed] [Google Scholar]
Shapiro SL, Bootzin RR, Figueredo AJ, Lopez AM. Schwartz GE. The efficacy of mindfulness-based stress reduction in the treatment of sleep disturbance in women with breast cancer: an exploratory study. J. Psychosom. Res. 2003;54:85–91. doi: 10.1016/s0022-3999(02)00546-9. [DOI] [PubMed] [Google Scholar]
Silberfarb PM, Hauri PJ, Oxman TE. Lash S. Insomnia in cancer patients. Soc. Sci. Med. 1985;20:849–850. doi: 10.1016/0277-9536(85)90340-5. [DOI] [PubMed] [Google Scholar]
Wright CE, Schnur JB, Montgomery GH. Bovbjerg DH. Psychological factors associated with poor sleep prior to breast surgery: an exploratory study. Behav. Med. 2010;36:85–91. doi: 10.1080/08964280903521305. [DOI] [PubMed] [Google Scholar]
Wu HS, Davis JE, Padiyar JP. Yarandi H. A comparison of disrupted sleep patterns in women with cancer-related fatigue and postmenopausal women without cancer. Eur. J. Oncol. Nurs. 2011;15:318–324. doi: 10.1016/j.ejon.2010.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
Berger AM, Hertzog M, Geary CR, Fischer P. Farr L. Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors. J. Cancer Surviv. 2012;6:305–314. doi: 10.1007/s11764-012-0218-x. [DOI] [PubMed] [Google Scholar]
Berger AM, Visovsky C, Hertzog M, Holtz S. Loberiza FR., Jr Usual and worst symptom severity and interference with function in breast cancer survivors. J. Support. Oncol. 2012;10:112–118. doi: 10.1016/j.suponc.2011.11.001. [DOI] [PubMed] [Google Scholar]
Berger AM, Wielgus K, Hertzog M, Fischer P. Farr L. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. J. Support. Oncol. 2010;18:105–114. doi: 10.1007/s00520-009-0636-0. [DOI] [PubMed] [Google Scholar]
Bower JE, Garet D, Sternlieb B, Ganz PA, Irwin MR, Olmstead R, et al. Yoga for persistent fatigue in breast cancer survivors: a randomized controlled trial. Cancer. 2012;118:3766–3775. doi: 10.1002/cncr.26702. [DOI] [PMC free article] [PubMed] [Google Scholar]
Boyd AD, Brown D, Henrickson C, Hampton J, Zhu B, Almani F, et al. Screening for depression, sleep-related disturbances, and anxiety in patients with adenocarcinoma of the pancreas: a preliminary study. ScientificWorldJournal. 2012;2012:1–6. doi: 10.1100/2012/650707. [DOI] [PMC free article] [PubMed] [Google Scholar]
Brant JM, Beck SL, Dudley WN, Cobb P, Pepper G. Miaskowski C. Symptom trajectories during chemotherapy in outpatients with lung cancer colorectal cancer, or lymphoma. Eur. J. Oncol. Nurs. 2011;15:470–477. doi: 10.1016/j.ejon.2010.12.002. [DOI] [PubMed] [Google Scholar]
Brown JK, Cooley ME, Chernecky C. Sarna L. A symptom cluster and sentinel symptom experienced by women with lung cancer. Oncol. Nurs. Forum. 2011;38:E425–E435. doi: 10.1188/11.ONF.E425-E435. [DOI] [PubMed] [Google Scholar]
Cho MH, Dodd MJ, Cooper BA. Miaskowski C. Comparisons of exercise dose and symptom severity between exercisers and nonexercisers in women during and after cancer treatment. J. Pain Symptom Manage. 2012;43:842–854. doi: 10.1016/j.jpainsymman.2011.05.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
Clevenger L, Schrepf A, Christensen D, DeGeest K, Bender D, Ahmed A, et al. Sleep disturbance, cytokines, and fatigue in women with ovarian cancer. Brain Behav. Immun. 2012;26:1037–1044. doi: 10.1016/j.bbi.2012.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
Coleman EA, Goodwin JA, Kennedy R, Coon SK, Richards K, Enderlin C, et al. Effects of exercise on fatigue, sleep, and performance: a randomized trial. Oncol. Nurs. Forum. 2012;39:468–477. doi: 10.1188/12.ONF.468-477. [DOI] [PMC free article] [PubMed] [Google Scholar]
Dedert E, Lush E, Chagpar A, Dhabhar FS, Segerstrom SC, Spiegel D, et al. Stress, coping, and circadian disruption among women awaiting breast cancer surgery. Ann. Behav. Med. 2012;44:10–20. doi: 10.1007/s12160-012-9352-y. [DOI] [PubMed] [Google Scholar]
Dhruva A, Miaskowski C, Abrams D, Acree M, Cooper B, Goodman S, et al. Yoga breathing for cancer chemotherapy-associated symptoms and quality of life: results of a pilot randomized controlled trial. J. Altern. Complement. Med. 2012;18:473–479. doi: 10.1089/acm.2011.0555. [DOI] [PMC free article] [PubMed] [Google Scholar]
Jim HS, Small B, Faul LA, Franzen J, Apte S. Jacobsen PB. Fatigue, depression, sleep, and activity during chemotherapy: daily and intraday variation and relationships among symptom changes. Ann. Behav. Med. 2011;42:321–333. doi: 10.1007/s12160-011-9294-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
Dhruva A, Paul SM, Cooper BA, Lee K, West C, Aouizerat BE, et al. A longitudinal study of measures of objective and subjective sleep disturbance in patients with breast cancer before, during, and after radiation therapy. J. Pain Symptom Manage. 2012;44:215–228. doi: 10.1016/j.jpainsymman.2011.08.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
Dickerson SS, Sabbah EA, Ziegler P, Chen H, Steinbrenner LM. Dean G. The experience of a diagnosis of advanced lung cancer: sleep is not a priority when living my life. Oncol. Nurs. Forum. 2012;39:492–499. doi: 10.1188/12.ONF.492-499. [DOI] [PubMed] [Google Scholar]
Dimsdale JE, Ball ED, Carrier E, Wallace M, Holman P, Mulroney C, et al. Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies. Support. Care Cancer. 2011;19:2015–2020. doi: 10.1007/s00520-010-1052-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
Gallicchio L, MacDonald R, Wood B, Rushovich E. Helzlsouer KJ. Menopausal-type symptoms among breast cancer patients on aromatase inhibitor therapy. Climacteric. 2012;15:339–349. doi: 10.3109/13697137.2011.620658. [DOI] [PubMed] [Google Scholar]
Gerber LH, Stout N, McGarvey C, Soballe P, Shieh CY, Diao G, et al. Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support. Care Cancer. 2011;19:1581–1591. doi: 10.1007/s00520-010-0986-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
Carpenter JS, Burns DS, Wu J, Otte JL, Schneider B, Ryker K, et al. Paced respiration for vasomotor and other menopausal symptoms: a randomized, controlled trial. J. Gen. Intern. Med. 2013;28:193–200. doi: 10.1007/s11606-012-2202-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
Jensen MP, Gralow JR, Braden A, Gertz KJ, Fann JR. Syrjala KL. Hypnosis for symptom management in women with breast cancer: a pilot study. Int. J. Clin. Exp. Hypn. 2012;60:135–159. doi: 10.1080/00207144.2012.648057. [DOI] [PMC free article] [PubMed] [Google Scholar]
Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, et al. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav. Immun. 2012;26:706–713. doi: 10.1016/j.bbi.2012.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
Liu L, Rissling M, Natarajan L, Fiorentino L, Mills PJ, Dimsdale JE, et al. The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy. Sleep. 2012;35:237–245. doi: 10.5665/sleep.1630. [DOI] [PMC free article] [PubMed] [Google Scholar]
Matthews EE, Schmiege SJ, Cook PF, Berger AM. Aloia MS. Adherence to cognitive behavioral therapy for insomnia (CBTI) among women following primary breast cancer treatment: a pilot study. Behav. Sleep Med. 2012;10:217–229. doi: 10.1080/15402002.2012.666220. [DOI] [PubMed] [Google Scholar]
Ritterband LM, Bailey ET, Thorndike FP, Lord HR, Farrell-Carnahan L. Baum LD. Initial evaluation of an Internet intervention to improve the sleep of cancer survivors with insomnia. Psychooncology. 2012;21:695–705. doi: 10.1002/pon.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
Roscoe JA, Perlis ML, Pigeon WR, O'Neill KH, Heckler CE, Matteson-Rusby SE, et al. Few changes observed in polysomnographic-assessed sleep before and after completion of chemotherapy. J. Psychosom. Res. 2011;71:423–428. doi: 10.1016/j.jpsychores.2011.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
Carlson LE, Campbell TS, Garland SN. Grossman P. Associations among salivary cortisol, melatonin, catecholamines, sleep quality and stress in women with breast cancer and healthy controls. J. Behav. Med. 2007;30:45–58. doi: 10.1007/s10865-006-9082-3. [DOI] [PubMed] [Google Scholar]
Carlson LE, Speca M, Patel KD. Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004;29:448–474. doi: 10.1016/s0306-4530(03)00054-4. [DOI] [PubMed] [Google Scholar]
Casault L, Savard J, Ivers H, Savard MH. Simard S. Utilization of hypnotic medication in the context of cancer: predictors and frequency of use. Support. Care Cancer. 2012;20:1203–1210. doi: 10.1007/s00520-011-1199-4. [DOI] [PubMed] [Google Scholar]
Davidson JR, Feldman-Stewart D, Brennenstuhl S. Ram S. How to provide insomnia interventions to people with cancer: insights from patients. Psychooncology. 2007;16:1028–1038. doi: 10.1002/pon.1183. [DOI] [PubMed] [Google Scholar]
Davidson JR, Waisberg JL, Brundage MD. MacLean AW. Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors. Psychooncology. 2001;10:389–397. doi: 10.1002/pon.525. [DOI] [PubMed] [Google Scholar]
Hadi S, Fan G, Hird AE, Kirou-Mauro A, Filipczak LA. Chow E. Symptom clusters in patients with cancer with metastatic bone pain. J. Palliat. Med. 2008;11:591–600. doi: 10.1089/jpm.2007.0145. [DOI] [PubMed] [Google Scholar]
Hadi S, Zhang L, Hird A, de Sa E. Chow E. Validation of symptom clusters in patients with metastatic bone pain. Curr. Oncol. 2008;15:211–218. doi: 10.3747/co.v15i5.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
Khan L, Uy C, Nguyen J, Chow E, Zhang L, Zeng L, et al. Self-reported rates of sleep disturbance in patients with symptomatic bone metastases attending an outpatient radiotherapy clinic. J. Palliat. Med. 2011;14:708–714. doi: 10.1089/jpm.2010.0491. [DOI] [PubMed] [Google Scholar]
Payne RJ, Hier MP, Kost KM, Black MJ, Zeitouni AG, Frenkiel S, et al. High prevalence of obstructive sleep apnea among patients with head and neck cancer. J. Otolaryngol. 2005;34:304–311. doi: 10.2310/7070.2005.34502. [DOI] [PubMed] [Google Scholar]
Quesnel C, Savard J, Simard S, Ivers H. Morin CM. Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. J. Consult. Clin. Psychol. 2003;71:189–200. [PubMed] [Google Scholar]
Savard J, Davidson JR, Ivers H, Quesnel C, Rioux D, Dupere V, et al. The association between nocturnal hot flashes and sleep in breast cancer survivors. J. Pain Symptom Manage. 2004;27:513–522. doi: 10.1016/j.jpainsymman.2003.10.013. [DOI] [PubMed] [Google Scholar]
Savard J, Ivers H, Villa J, Caplette-Gingras A. Morin CM. Natural course of insomnia comorbid with cancer: an 18-month longitudinal study. J. Clin. Oncol. 2011;29:3580–3586. doi: 10.1200/JCO.2010.33.2247. [DOI] [PubMed] [Google Scholar]
Savard J, Liu L, Natarajan L, Rissling MB, Neikrug AB, He F, et al. Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep. 2009;32:1155–1160. doi: 10.1093/sleep/32.9.1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
Savard J, Simard S, Blanchet J, Ivers H. Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 2001;24:583–590. doi: 10.1093/sleep/24.5.583. [DOI] [PubMed] [Google Scholar]
Savard J, Simard S, Hervouet S, Ivers H, Lacombe L. Fradet Y. Insomnia in men treated with radical prostatectomy for prostate cancer. Psychooncology. 2005;14:147–156. doi: 10.1002/pon.830. [DOI] [PubMed] [Google Scholar]
Savard J, Simard S, Ivers H. Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: immunologic effects. J. Clin. Oncol. 2005;23:6097–6106. doi: 10.1200/JCO.2005.12.513. [DOI] [PubMed] [Google Scholar]
Savard J, Simard S, Ivers H. Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J. Clin. Oncol. 2005;23:6083–6096. doi: 10.1200/JCO.2005.09.548. [DOI] [PubMed] [Google Scholar]
Savard J, Villa J, Ivers H, Simard S. Morin CM. Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J. Clin. Oncol. 2009;27:5233–5239. doi: 10.1200/JCO.2008.21.6333. [DOI] [PubMed] [Google Scholar]
Savard J, Villa J, Simard S, Ivers H. Morin CM. Feasibility of a self-help treatment for insomnia comorbid with cancer. Psychooncology. 2011;20:1013–1019. doi: 10.1002/pon.1818. [DOI] [PubMed] [Google Scholar]
Savard MH, Savard J, Simard S. Ivers H. Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncology. 2004;14:429–441. doi: 10.1002/pon.860. [DOI] [PubMed] [Google Scholar]
Savard MH, Savard J, Trudel-Fitzgerald C, Ivers H. Quesnel C. Changes in self-reported hot flashes and their association with concurrent changes in insomnia symptoms among women with breast cancer. Menopause. 2011;18:985–993. doi: 10.1097/gme.0b013e31820db6a1. [DOI] [PubMed] [Google Scholar]
Sela RA, Watanabe S. Nekolaichuk CL. Sleep disturbances in palliative cancer patients attending a pain and symptom control clinic. Palliat. Support. Care. 2005;3:23–31. doi: 10.1017/s1478951505050042. [DOI] [PubMed] [Google Scholar]
Stevinson C, Steed H, Faught W, Tonkin K, Vallance JK, Ladha AB, et al. Physical activity in ovarian cancer survivors: associations with fatigue, sleep, and psychosocial functioning. Int. J. Gynecol. Cancer. 2009;19:73–78. doi: 10.1111/IGC.0b013e31819902ec. [DOI] [PubMed] [Google Scholar]
Tremblay V, Savard J. Ivers H. Predictors of the effect of cognitive behavioral therapy for chronic insomnia comorbid with breast cancer. J. Consult. Clin. Psychol. 2009;77:742–750. doi: 10.1037/a0015492. [DOI] [PubMed] [Google Scholar]
Cerrone R, Giani L, Galbiati B, Messina G, Casiraghi M, Proserpio E, et al. Efficacy of HT 7 point acupressure stimulation in the treatment of insomnia in cancer patients and in patients suffering from disorders other than cancer. Minerva Med. 2008;99:535–537. [PubMed] [Google Scholar]
Dahl AA, Nesvold IL, Reinertsen KV. Fossa SD. Arm/shoulder problems and insomnia symptoms in breast cancer survivors: cross-sectional, controlled and longitudinal observations. Sleep Med. 2011;12:584–590. doi: 10.1016/j.sleep.2011.01.011. [DOI] [PubMed] [Google Scholar]
Dominguez-Ortega L, Cubedo-Cervera R, Cortes-Funes H. Diaz-Gallego E. Sleep protects against chemotherapy induced emesis. Cancer. 1996;77:1566–1570. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1566::AID-CNCR21>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J. Clin. Oncol. 2008;26:1–9. doi: 10.1200/JCO.2007.13.9006. [DOI] [PubMed] [Google Scholar]
Fernandes R, Stone P, Andrews P, Morgan R. Sharma S. Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: evaluation of diagnostic criteria for cancer-related fatigue. J. Pain Symptom Manage. 2006;32:245–254. doi: 10.1016/j.jpainsymman.2006.03.014. [DOI] [PubMed] [Google Scholar]
Fleming L, Gillespie S. Espie CA. The development and impact of insomnia on cancer survivors: a qualitative analysis. Psychooncology. 2010;19:991–996. doi: 10.1002/pon.1652. [DOI] [PubMed] [Google Scholar]
Frisk J, Kallstrom AC, Wall N, Fredrikson M. Hammar M. Acupuncture improves health-related quality-of-life (HRQoL) and sleep in women with breast cancer and hot flushes. Support. Care Cancer. 2012;20:715–724. doi: 10.1007/s00520-011-1134-8. [DOI] [PubMed] [Google Scholar]
Gibbins J, McCoubrie R, Kendrick AH, Senior-Smith G, Davies AN. Hanks GW. Sleep-wake disturbances in patients with advanced cancer and their family carers. J. Pain Symptom Manage. 2009;38:860–870. doi: 10.1016/j.jpainsymman.2009.04.025. [DOI] [PubMed] [Google Scholar]
Goedendorp MM, Gielissen MF, Verhagen CA, Peters ME. Bleijenberg G. Severe fatigue and related factors in cancer patients before the initiation of treatment. Br. J. Cancer. 2008;99:1408–1414. doi: 10.1038/sj.bjc.6604739. [DOI] [PMC free article] [PubMed] [Google Scholar]
Gogenur I, Wildschiotz G. Rosenberg J. Circadian distribution of sleep phases after major abdominal surgery. Br. J. Anaesth. 2008;100:45–49. doi: 10.1093/bja/aem340. [DOI] [PubMed] [Google Scholar]
Henoch I, Ploner A. Tishelman C. Increasing stringency in symptom cluster research: a methodological exploration of symptom clusters in patients with inoperable lung cancer. Oncol. Nurs. Forum. 2009;36:E282–E292. doi: 10.1188/09.ONF.E283-E292. [DOI] [PubMed] [Google Scholar]
Hoekstra J, Vernooij-Dassen MJ, de Vos R. Bindels PJ. The added value of assessing the ‘most troublesome’ symptom among patients with cancer in the palliative phase. Patient Educ. Couns. 2007;65:223–229. doi: 10.1016/j.pec.2006.08.001. [DOI] [PubMed] [Google Scholar]
Hoijer U, Ejnell H. Hedner J. Obstructive sleep apnea in patients with pharyngeal tumours. Acta Otolaryngol. 1992;112:138–143. doi: 10.3109/00016489209100795. [DOI] [PubMed] [Google Scholar]
Hunter MS, Coventry S, Hamed H, Fentiman I. Grunfeld EA. Evaluation of a group cognitive behavioural intervention for women suffering from menopausal symptoms following breast cancer treatment. Psychooncology. 2009;18:560–563. doi: 10.1002/pon.1414. [DOI] [PubMed] [Google Scholar]
Hunter MS, Coventry S, Mendes N. Grunfeld EA. Menopausal symptoms following breast cancer treatment: a qualitative investigation of cognitive and behavioural responses. Maturitas. 2009;63:336–340. doi: 10.1016/j.maturitas.2009.06.003. [DOI] [PubMed] [Google Scholar]
Hunter MS, Grunfeld EA, Mittal S, Sikka P, Ramirez AJ, Fentiman I, et al. Menopausal symptoms in women with breast cancer: prevalence and treatment preferences. Psychooncology. 2004;13:769–778. doi: 10.1002/pon.793. [DOI] [PubMed] [Google Scholar]
Jimenez A, Madero R, Alonso A, Martinez-Marin V, Vilches Y, Martinez B, et al. Symptom clusters in advanced cancer. J. Pain Symptom Manage. 2011;42:24–31. doi: 10.1016/j.jpainsymman.2010.10.266. [DOI] [PubMed] [Google Scholar]
Le Guen Y, Gagnadoux F, Hureaux J, Jeanfaivre T, Meslier N, Racineux JL, et al. Sleep disturbances and impaired daytime functioning in outpatients with newly diagnosed lung cancer. Lung Cancer. 2007;58:139–143. doi: 10.1016/j.lungcan.2007.05.021. [DOI] [PubMed] [Google Scholar]
Levin RD, Daehler MA, Grutsch JF, Quiton J, Lis CG, Peterson C, et al. Circadian function in patients with advanced non-small-cell lung cancer. Br. J. Cancer. 2005;93:1202–1208. doi: 10.1038/sj.bjc.6602859. [DOI] [PMC free article] [PubMed] [Google Scholar]
Mercadante S, Girelli D. Casuccio A. Sleep disorders in advanced cancer patients: prevalence and factors associated. Support. Care Cancer. 2004;12:355–359. doi: 10.1007/s00520-004-0623-4. [DOI] [PubMed] [Google Scholar]
Mormont MC, Waterhouse J, Bleuzen P, Giacchetti S, Jami A, Bogdan A, et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin. Cancer Res. 2000;6:3038–3045. [PubMed] [Google Scholar]
Munro AJ. Potter S. A quantitative approach to the distress caused by symptoms in patients treated with radical radiotherapy. Br. J. Cancer. 1996;74:640–647. doi: 10.1038/bjc.1996.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
Nesse W, Hoekema A, Stegenga B, van der Hoeven JH, de Bont LG. Roodenburg JL. Prevalence of obstructive sleep apnoea following head and neck cancer treatment: a cross-sectional study. Oral Oncol. 2006;42:108–114. doi: 10.1016/j.oraloncology.2005.06.022. [DOI] [PubMed] [Google Scholar]
Pasquini M, Speca A. Biondi M. Quetiapine for tamoxifen-induced insomnia in women with breast cancer. Psychosomatics. 2009;50:159–161. doi: 10.1176/appi.psy.50.2.159. [DOI] [PubMed] [Google Scholar]
Pollak L, Shpirer I, Rabey JM, Klein C. Schiffer J. Polysomnography in patients with intracranial tumors before and after operation. Acta Neurol. Scand. 2004;109:56–60. doi: 10.1034/j.1600-0404.2003.00176.x. [DOI] [PubMed] [Google Scholar]
Richardson A. Ream E. The experience of fatigue and other symptoms in patients receiving chemotherapy. Eur. J. Cancer Care (Engl.) 1996;5(Suppl. 2):24–30. doi: 10.1111/j.1365-2354.1996.tb00248.x. [DOI] [PubMed] [Google Scholar]
Rischer J, Scherwath A, Zander AR, Koch U. Schulz-Kindermann F. Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation. Bone Marrow Transplant. 2009;44:121–128. doi: 10.1038/bmt.2008.430. [DOI] [PubMed] [Google Scholar]
Servaes P, Verhagen S. Bleijenberg G. Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann. Oncol. 2002;13:589–598. doi: 10.1093/annonc/mdf082. [DOI] [PubMed] [Google Scholar]
Grov EK, Fossa SD. Dahl AA. Insomnia in elderly cancer survivors–a population-based controlled study of associations with lifestyle, morbidity, and psychosocial factors. Results from the Health Survey of North-Trondelag County (HUNT-2). Insomnia in elderly cancer survivors. Support. Care Cancer. 2011;19:1319–1326. doi: 10.1007/s00520-010-0948-0. [DOI] [PubMed] [Google Scholar]
Simeit R, Deck R. Conta-Marx B. Sleep management training for cancer patients with insomnia. Support. Care Cancer. 2004;12:176–183. doi: 10.1007/s00520-004-0594-5. [DOI] [PubMed] [Google Scholar]
Steffen A, Graefe H, Gehrking E, Konig IR. Wollenberg B. Sleep apnoea in patients after treatment of head neck cancer. Acta Otolaryngol. 2009;129:1300–1305. doi: 10.3109/00016480802613113. [DOI] [PubMed] [Google Scholar]
Thulin H, Kreicbergs U, Wijkstrom H, Steineck G. Henningsohn L. Sleep disturbances decrease self-assessed quality of life in individuals who have undergone cystectomy. J. Urol. 2010;184:198–202. doi: 10.1016/j.juro.2010.03.009. [DOI] [PubMed] [Google Scholar]
van der Klaauw AA, Dekkers OM, Pereira AM, van Kralingen KW. Romijn JA. Increased daytime somnolence despite normal sleep patterns in patients treated for nonfunctioning pituitary macroadenoma. J. Clin. Endocrinol. Metab. 2007;92:3898–3903. doi: 10.1210/jc.2007-0944. [DOI] [PubMed] [Google Scholar]
Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, et al. Sleep duration and breast cancer: a prospective cohort study. Cancer Res. 2005;65:9595–9600. doi: 10.1158/0008-5472.CAN-05-2138. [DOI] [PubMed] [Google Scholar]
Wilcock A, England R, El Khoury B, Frisby J, Howard P, Bell S, et al. The prevalence of nocturnal hypoxemia in advanced cancer. J. Pain Symptom Manage. 2008;36:351–357. doi: 10.1016/j.jpainsymman.2007.11.007. [DOI] [PubMed] [Google Scholar]
Haest K, Kumar A, Van Calster B, Leunen K, Smeets A, Amant F, et al. Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up. Ann. Oncol. 2012;23:1449–1454. doi: 10.1093/annonc/mdr478. [DOI] [PubMed] [Google Scholar]
Laugsand EA, Jakobsen G, Kaasa S. Klepstad P. Inadequate symptom control in advanced cancer patients across Europe. Support. Care Cancer. 2011;19:2005–2014. doi: 10.1007/s00520-010-1051-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
Manas A, Ciria JP, Fernandez MC, Gonzalvez ML, Morillo V, Perez M, et al. Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health. Clin. Transl. Oncol. 2011;13:656–663. doi: 10.1007/s12094-011-0711-0. [DOI] [PubMed] [Google Scholar]
Mann E, Smith MJ, Hellier J, Balabanovic JA, Hamed H, Grunfeld EA, et al. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol. 2012;13:309–318. doi: 10.1016/S1470-2045(11)70364-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
Rostock M, Fischer J, Mumm A, Stammwitz U, Saller R. Bartsch HH. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints—a prospective observational study. Gynecol. Endocrinol. 2011;27:844–848. doi: 10.3109/09513590.2010.538097. [DOI] [PubMed] [Google Scholar]
Sharma N, Hansen CH, O'Connor M, Thekkumpurath P, Walker J, Kleiboer A, et al. Sleep problems in cancer patients: prevalence and association with distress and pain. Psychooncology. 2012;21:1003–1009. doi: 10.1002/pon.2004. [DOI] [PubMed] [Google Scholar]
Taskila T, de Boer AG, van Dijk FJ. Verbeek JH. Fatigue and its correlates in cancer patients who had returned to work: a cohort study. Psychooncology. 2011;20:1236–1241. doi: 10.1002/pon.1843. [DOI] [PubMed] [Google Scholar]
Malone M, Harris AL. Luscombe DK. Assessment of the impact of cancer on work, recreation, home management and sleep using a general health status measure. J. R. Soc. Med. 1994;87:386–389. doi: 10.1177/014107689408700705. [DOI] [PMC free article] [PubMed] [Google Scholar]
Banthia R, Malcarne VL, Ko CM, Varni JW. Sadler GR. Fatigued breast cancer survivors: the role of sleep quality, depressed mood, stage and age. Psychol. Health. 2009;24:965–980. doi: 10.1080/08870440802110831. [DOI] [PMC free article] [PubMed] [Google Scholar]
Akechi T, Okuyama T, Akizuki N, Shimizu K, Inagaki M, Fujimori M, et al. Associated and predictive factors of sleep disturbance in advanced cancer patients. Psychooncology. 2007;16:888–894. doi: 10.1002/pon.1122. [DOI] [PubMed] [Google Scholar]
Barichello E, Sawada NO, Sonobe HM. Zago MM. Quality of sleep in postoperative surgical oncologic patients. Rev. Lat. Am. Enfermagem. 2009;17:481–488. doi: 10.1590/s0104-11692009000400008. [DOI] [PubMed] [Google Scholar]
Beck SL, Berger AM, Barsevick AM, Wong B, Stewart KA. Dudley WN. Sleep quality after initial chemotherapy for breast cancer. Support. Care Cancer. 2010;18:679–689. doi: 10.1007/s00520-009-0662-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
Cankurtaran ES, Ozalp E, Soygur H, Akbiyik DI, Turhan L. Alkis N. Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine. Support. Care Cancer. 2008;16:1291–1298. doi: 10.1007/s00520-008-0425-1. [DOI] [PubMed] [Google Scholar]
Chen ML, Yu CT. Yang CH. Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy. Lung Cancer. 2008;62:391–400. doi: 10.1016/j.lungcan.2008.03.016. [DOI] [PubMed] [Google Scholar]
Furlani R. Ceolim MF. Sleep quality of women with gynecological and breast cancer. Rev. Lat. Am. Enfermagem. 2006;14:872–878. doi: 10.1590/s0104-11692006000600007. [DOI] [PubMed] [Google Scholar]
Israel Y, Cervantes O, Abrahao M, Ceccon FP, Marques Filho MF, Nascimento LA, et al. Obstructive sleep apnea in patients undergoing supracricoid horizontal or frontolateral vertical partial laryngectomy. Otolaryngol. Head Neck Surg. 2006;135:911–916. doi: 10.1016/j.otohns.2006.02.030. [DOI] [PubMed] [Google Scholar]
Kim SW, Shin IS, Kim JM, Kim YC, Kim KS, Kim KM, et al. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. Psychiatry Clin. Neurosci. 2008;62:75–83. doi: 10.1111/j.1440-1819.2007.01778.x. [DOI] [PubMed] [Google Scholar]
Kuo HH, Chiu MJ, Liao WC. Hwang SL. Quality of sleep and related factors during chemotherapy in patients with stage I/II breast cancer. J. Formos. Med. Assoc. 2006;105:64–69. doi: 10.1016/S0929-6646(09)60110-8. [DOI] [PubMed] [Google Scholar]
Matsuo N. Morita T. Efficacy, safety, and cost effectiveness of intravenous midazolam and flunitrazepam for primary insomnia in terminally ill patients with cancer: a retrospective multicenter audit study. J. Palliat. Med. 2007;10:1054–1062. doi: 10.1089/jpm.2007.0016. [DOI] [PubMed] [Google Scholar]
Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Galanos A. Vlahos L. Depression, hopelessness, and sleep in cancer patients' desire for death. Int. J. Psychiatry Med. 2007;37:201–211. doi: 10.2190/0509-7332-388N-566W. [DOI] [PubMed] [Google Scholar]
Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Gennatas K, Smyrniotis V, et al. The relationship of subjective sleep quality, pain, and quality of life in advanced cancer patients. Sleep. 2007;30:737–742. doi: 10.1093/sleep/30.6.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Patiraki E, Galanos A, et al. Sleep quality in advanced cancer patients. J. Psychosom. Res. 2007;62:527–533. doi: 10.1016/j.jpsychores.2006.11.008. [DOI] [PubMed] [Google Scholar]
Taguchi T, Yano M. Kido Y. Influence of bright light therapy on postoperative patients: a pilot study. Intensive Crit. Care Nurs. 2007;23:289–297. doi: 10.1016/j.iccn.2007.04.004. [DOI] [PubMed] [Google Scholar]
Wang RC, Wang SJ, Chang YC. Lin CC. Mood state and quality of sleep in cancer pain patients: a comparison to chronic daily headache. J. Pain Symptom Manage. 2007;33:32–39. doi: 10.1016/j.jpainsymman.2006.06.013. [DOI] [PubMed] [Google Scholar]
Wang SY, Tsai CM, Chen BC, Lin CH. Lin CC. Symptom clusters and relationships to symptom interference with daily life in Taiwanese lung cancer patients. J. Pain Symptom Manage. 2008;35:258–266. doi: 10.1016/j.jpainsymman.2007.03.017. [DOI] [PubMed] [Google Scholar]
Zhao Y, Wang XS. Li PP. Investigation of common symptoms of cancer and reliability analysis. Chin. J. Integr. Med. 2007;13:195–199. doi: 10.1007/s11655-007-0195-5. [DOI] [PubMed] [Google Scholar]
Cheng KK. Lee DT. Effects of pain, fatigue, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer. Crit. Rev. Oncol. Hematol. 2011;78:127–137. doi: 10.1016/j.critrevonc.2010.03.002. [DOI] [PubMed] [Google Scholar]
Colagiuri B, Christensen S, Jensen AB, Price MA, Butow PN. Zachariae R. Prevalence and predictors of sleep difficulty in a national cohort of women with primary breast cancer three to four months postsurgery. J. Pain Symptom Manage. 2011;42:710–720. doi: 10.1016/j.jpainsymman.2011.02.012. [DOI] [PubMed] [Google Scholar]
Demiralp M, Oflaz F. Komurcu S. Effects of relaxation training on sleep quality and fatigue in patients with breast cancer undergoing adjuvant chemotherapy. J. Clin. Nurs. 2010;19:1073–1083. doi: 10.1111/j.1365-2702.2009.03037.x. [DOI] [PubMed] [Google Scholar]
Evangelista AL. Santos EM. Cluster of symptoms in women with breast cancer treated with curative intent. Support. Care Cancer. 2012;20:1499–1506. doi: 10.1007/s00520-011-1238-1. [DOI] [PubMed] [Google Scholar]
Huang TW. Lin CC. The mediating effects of depression on sleep disturbance and fatigue: symptom clusters in patients with hepatocellular carcinoma. Cancer Nurs. 2009;32:398–403. doi: 10.1097/NCC.0b013e3181ac6248. [DOI] [PubMed] [Google Scholar]
Humpel N. Iverson DC. Sleep quality, fatigue and physical activity following a cancer diagnosis. Eur. J. Cancer Care (Engl.) 2010;19:761–768. doi: 10.1111/j.1365-2354.2009.01126.x. [DOI] [PubMed] [Google Scholar]
Mystakidou K, Parpa E, Tsilika E, Gennatas C, Galanos A. Vlahos L. How is sleep quality affected by the psychological and symptom distress of advanced cancer patients? Palliat. Med. 2009;23:46–53. doi: 10.1177/0269216308098088. [DOI] [PubMed] [Google Scholar]
Qian W, Haight J, Poon I, Enepekides D. Higgins KM. Sleep apnea in patients with oral cavity and oropharyngeal cancer after surgery and chemoradiation therapy. Otolaryngol. Head Neck Surg. 2010;143:248–252. doi: 10.1016/j.otohns.2010.02.032. [DOI] [PubMed] [Google Scholar]
Vadiraja SH, Rao MR, Nagendra RH, Nagarathna R, Rekha M, Vanitha N, et al. Effects of yoga on symptom management in breast cancer patients: a randomized controlled trial. Int. J. Yoga. 2009;2:73–79. doi: 10.4103/0973-6131.60048. [DOI] [PMC free article] [PubMed] [Google Scholar]
Wang SY, Chang HJ. Lin CC. Sleep disturbances among patients with non-small cell lung cancer in Taiwan: congruence between sleep log and actigraphy. Cancer Nurs. 2010;33:E11–E17. doi: 10.1097/NCC.0b013e3181b3278e. [DOI] [PubMed] [Google Scholar]
Yang HL, Chen XP, Lee KC, Fang FF. Chao YF. The effects of warm-water footbath on relieving fatigue and insomnia of the gynecologic cancer patients on chemotherapy. Cancer Nurs. 2010;33:454–460. doi: 10.1097/NCC.0b013e3181d761c1. [DOI] [PubMed] [Google Scholar]
Tzeng JI, Fu YW. Lin CC. Validity and reliability of the Taiwanese version of the Pittsburgh Sleep Quality Index in cancer patients. Int. J. Nurs. Stud. 2012;49:102–108. doi: 10.1016/j.ijnurstu.2011.08.004. [DOI] [PubMed] [Google Scholar]
Chu TL, Yu WP, Chen SC, Peng HL. Wu MJ. Comparison of differences and determinants between presence and absence of sleep disturbance in hepatocellular carcinoma patients. Cancer Nurs. 2011;34:354–360. doi: 10.1097/NCC.0b013e3182037bf3. [DOI] [PubMed] [Google Scholar]
Feng Y, Wang XY, Li SD, Zhang Y, Wang HM, Li M, et al. Clinical research of acupuncture on malignant tumor patients for improving depression and sleep quality. J. Tradit. Chin. Med. 2011;31:199–202. doi: 10.1016/s0254-6272(11)60042-3. [DOI] [PubMed] [Google Scholar]
Courneya KS, Sellar CM, Trinh L, Forbes CC, Stevinson C, McNeely ML, et al. A randomized trial of aerobic exercise and sleep quality in lymphoma patients receiving chemotherapy or no treatments. Cancer Epidemiol. Biomarkers Prev. 2012;21:887–894. doi: 10.1158/1055-9965.EPI-12-0075. [DOI] [PubMed] [Google Scholar]
Hofso K, Miaskowski C, Bjordal K, Cooper BA. Rustoen T. Previous chemotherapy influences the symptom experience and quality of life of women with breast cancer prior to radiation therapy. Cancer Nurs. 2012;35:167–177. doi: 10.1097/NCC.0b013e31821f5eb5. [DOI] [PubMed] [Google Scholar]
Jane SW, Chen SL, Wilkie DJ, Lin YC, Foreman SW, Beaton RD, et al. Effects of massage on pain, mood status, relaxation, and sleep in Taiwanese patients with metastatic bone pain: a randomized clinical trial. Pain. 2011;152:2432–2442. doi: 10.1016/j.pain.2011.06.021. [DOI] [PubMed] [Google Scholar]
Kim HJ, Barsevick AM, Beck SL. Dudley W. Clinical subgroups of a psychoneurologic symptom cluster in women receiving treatment for breast cancer: a secondary analysis. Oncol. Nurs. Forum. 2012;39:E20–E30. doi: 10.1188/12.ONF.E20-E30. [DOI] [PubMed] [Google Scholar]
Kotronoulas GC, Papadopoulou CN, Papapetrou A. Patiraki E. Psychometric evaluation and feasibility of the Greek Pittsburgh Sleep Quality Index (GR-PSQI) in patients with cancer receiving chemotherapy. Support. Care Cancer. 2011;19:1831–1840. doi: 10.1007/s00520-010-1025-4. [DOI] [PubMed] [Google Scholar]
Liu Y, Xi QS, Xia S, Zhuang L, Zheng W. Yu S. Association between symptoms and their severity with survival time in hospitalized patients with far advanced cancer. J. Palliat. Med. 2011;25:682–690. doi: 10.1177/0269216311398301. [DOI] [PubMed] [Google Scholar]
Monas L, Csorba S, Kovalyo M, Zeligman R, Dror YF. Musgrave CF. The relationship of sleep disturbance and symptom severity, symptom interference, and hospitalization among Israeli inpatients with cancer. Oncol. Nurs. Forum. 2012;39:E361–E372. doi: 10.1188/12.ONF.E361-E372. [DOI] [PubMed] [Google Scholar]
Mota DD, Pimenta CA. Caponero R. Fatigue in colorectal cancer patients: prevalence and associated factors. Rev. Lat. Am. Enfermagem. 2012;20:495–503. doi: 10.1590/s0104-11692012000300010. [DOI] [PubMed] [Google Scholar]
Berger AM. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol. Nurs. Forum. 1998;25:51–62. [PubMed] [Google Scholar]
Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W. Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 2003;26:342–392. doi: 10.1093/sleep/26.3.342. [DOI] [PubMed] [Google Scholar]
Buysse DJ, Reynolds CF, III, Monk TH, Berman SR. Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213. doi: 10.1016/0165-1781(89)90047-4. [DOI] [PubMed] [Google Scholar]
Espie CA. Insomnia: conceptual issues in the development, persistence, and treatment of sleep disorder in adults. Annu. Rev. Psychol. 2002;53:215–243. doi: 10.1146/annurev.psych.53.100901.135243. [DOI] [PubMed] [Google Scholar]
Fry JM. Sleep disorders. Med. Clin. North Am. 1987;71:95–110. doi: 10.1016/s0025-7125(16)30885-9. [DOI] [PubMed] [Google Scholar]
Vena C, Parker K, Allen R, Bliwise D, Jain S. Kimble L. Sleep-wake disturbances and quality of life in patients with advanced lung cancer. Oncol. Nurs. Forum. 2006;33:761–769. doi: 10.1188/06.ONF.761-769. [DOI] [PubMed] [Google Scholar]
Freedman RR. Roehrs TA. Sleep disturbance in menopause. Menopause. 2007;14:826–829. doi: 10.1097/GME.0b013e3180321a22. [DOI] [PubMed] [Google Scholar]
Dzaja A, Arber S, Hislop J, Kerkhofs M, Kopp C, Pollmacher T, et al. Women's sleep in health and disease. J. Psychiatr. Res. 2005;39:55–76. doi: 10.1016/j.jpsychires.2004.05.008. [DOI] [PubMed] [Google Scholar]

[b1] Cleeland CS, Zhao F, Chang VT, Sloan JA, O'Mara AM, Gilman PB, et al. The symptom burden of cancer: evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer. 2013;119:4333–4340. doi: 10.1002/cncr.28376. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b2] Ancoli-Israel S, Moore PJ. Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur. J. Cancer Care. 2001;10:245–255. doi: 10.1046/j.1365-2354.2001.00263.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b3] Anderson KO, Getto CJ, Mendoza TR, Palmer SN, Wang XS, Reyes-Gibby CC, et al. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J. Pain Symptom Manage. 2003;25:307–318. doi: 10.1016/s0885-3924(02)00682-6. [DOI] [PubMed] [Google Scholar]

[b4] Beck SL, Schwartz AL, Towsley G, Dudley W. Barsevick A. Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J. Pain Symptom Manage. 2004;27:140–148. doi: 10.1016/j.jpainsymman.2003.12.002. [DOI] [PubMed] [Google Scholar]

[b5] Berger AM. Higginbotham P. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. Oncol. Nurs. Forum. 2000;27:1443–1448. [PubMed] [Google Scholar]

[b6] Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE. Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J. Clin. Oncol. 2000;18:743–753. doi: 10.1200/JCO.2000.18.4.743. [DOI] [PubMed] [Google Scholar]

[b7] Carpenter JS, Elam J, Ridner S, Carney P, Cherry G. Cucullu H. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol. Nurs. Forum. 2004;31:591–598. doi: 10.1188/04.onf.591-598. [DOI] [PubMed] [Google Scholar]

[b8] Davidson JR, MacLean AW, Brundage MD. Schulze K. Sleep disturbance in cancer patients. Soc. Sci. Med. 2002;54:1309–1321. doi: 10.1016/s0277-9536(01)00043-0. [DOI] [PubMed] [Google Scholar]

[b9] Dow KH, Ferrell BR, Leigh S, Ly J. Gulasekaram P. An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Res. Treat. 1996;39:261–273. doi: 10.1007/BF01806154. [DOI] [PubMed] [Google Scholar]

[b10] Engstrom CA, Strohl RA, Rose L, Lewandowski L. Stefanek ME. Sleep alterations in cancer patients. Cancer Nurs. 1999;22:143–148. doi: 10.1097/00002820-199904000-00006. [DOI] [PubMed] [Google Scholar]

[b11] Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S. Durrence HH. Sleep and quality of life in breast cancer patients. J. Pain Symptom Manage. 2002;24:471–480. doi: 10.1016/s0885-3924(02)00500-6. [DOI] [PubMed] [Google Scholar]

[b12] Koopman C, Nouriani B, Erickson V, Anupindi R, Butler LD, Bachmann MH, et al. Sleep disturbances in women with metastatic breast cancer. Breast J. 2002;8:362–370. doi: 10.1046/j.1524-4741.2002.08606.x. [DOI] [PubMed] [Google Scholar]

[b13] Lee K, Cho M, Miaskowski C. Dodd M. Impaired sleep and rhythms in persons with cancer. Sleep Med. Rev. 2004;8:199–212. doi: 10.1016/j.smrv.2003.10.001. [DOI] [PubMed] [Google Scholar]

[b14] Miaskowski C. Lee KA. Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J. Pain Symptom Manage. 1999;17:320–332. doi: 10.1016/s0885-3924(99)00008-1. [DOI] [PubMed] [Google Scholar]

[b15] Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T, et al. Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support. Care Cancer. 2000;8:215–222. doi: 10.1007/s005200050288. [DOI] [PubMed] [Google Scholar]

[b16] Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Matteson S, Rakita D, et al. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support. Care Cancer. 2002;10:329–336. doi: 10.1007/s00520-001-0317-0. [DOI] [PubMed] [Google Scholar]

[b17] Savard J. Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J. Clin. Oncol. 2001;19:895–908. doi: 10.1200/JCO.2001.19.3.895. [DOI] [PubMed] [Google Scholar]

[b18] Deimling GT, Kahana B, Bowman KF. Schaefer ML. Cancer survivorship and psychological distress in later life. Psychooncology. 2002;11:479–494. doi: 10.1002/pon.614. [DOI] [PubMed] [Google Scholar]

[b19] Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE. Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J. Natl. Cancer Inst. 2002;94:39–49. doi: 10.1093/jnci/94.1.39. [DOI] [PubMed] [Google Scholar]

[b20] Siefert ML, Hong F, Valcarce B. Berry DL. Patient and clinician communication of self-reported insomnia during ambulatory cancer care clinic visits. Cancer Nurs. 2013;37:E51–E59. doi: 10.1097/NCC.0b013e318283a7bc. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b21] Berger AM, Parker KP, Young-McCaughan S, Mallory GA, Barsevick AM, Beck SL, et al. Sleep wake disturbances in people with cancer and their caregivers: state of the science. Oncol. Nurs. Forum. 2005;32:E98–E126. doi: 10.1188/05.ONF.E98-E126. [DOI] [PubMed] [Google Scholar]

[b22] Vena C, Parker K, Cunningham M, Clark J. McMillan S. Continuing education: sleep-wake disturbances in people with cancer part I: an overview of sleep, sleep regulation, and effects of disease and treatment. Oncol. Nurs. Forum. 2004;31:735–746. doi: 10.1188/04.ONF.735-746. [DOI] [PubMed] [Google Scholar]

[b23] Institute NC. SEER Stat Fact Sheet: all cancer sites. Available at: http://seer.cancer.gov/statfacts/html/all.html (accessed 10 January 2014)

[b24] Institute NC. Survivorship-related statistics and graphs. Available at: http://cancercontrol.cancer.gov/ocs/prevalence/ (accessed 10 January 2014)

[b25] Oncology Nursing Society. Onzrcology nursing society 2009-2013 research Agenda. Available at: www.ons.org (accessed 21 January 2014)

[b26] Department of Health and Human Services. Bethesda: National Institutes of Health; 2011. Bringing science to life-NINR strategic plan. [Google Scholar]

[b27] American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994. [Google Scholar]

[b28] American Academy of Sleep Medicine. The international classification of sleep disorders: diagnostic and coding manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005. [Google Scholar]

[b29] Golbin AZ, Kravitz HM, Keith LG. Barkin RL. Sleep psychiatry. New York, NY: Taylor & Francis; 2004. [Google Scholar]

[b30] Moher D, Liberati A, Tetzlaff J. Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J. Clin. Epidemiol. 2009;62:1006–1012. doi: 10.1016/j.jclinepi.2009.06.005. [DOI] [PubMed] [Google Scholar]

[b31] Alfano CM, Lichstein KL, Vander Wal GS, Smith AW, Reeve BB, McTiernan A, et al. Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life. Breast Cancer Res. Treat. 2011;130:243–254. doi: 10.1007/s10549-011-1530-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b32] Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR, et al. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support. Care Cancer. 2006;14:201–209. doi: 10.1007/s00520-005-0861-0. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b33] Baldwin CM, Grant M, Wendel C, Hornbrook MC, Herrinton LJ, McMullen C, et al. Gender differences in sleep disruption and fatigue on quality of life among persons with ostomies. J. Clin. Sleep Med. 2009;5:335–343. [PMC free article] [PubMed] [Google Scholar]

[b34] Bardwell WA, Profant J, Casden DR, Dimsdale JE, Ancoli-Israel S, Natarajan L, et al. The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psychooncology. 2008;17:9–18. doi: 10.1002/pon.1192. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b35] Barsevick A, Beck SL, Dudley WN, Wong B, Berger AM, Whitmer K, et al. Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy. J. Pain Symptom Manage. 2010;40:200–216. doi: 10.1016/j.jpainsymman.2009.12.020. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b36] Barton DL, Atherton PJ, Bauer BA, Moore DF, Jr, Mattar BI, Lavasseur BI, et al. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5) J. Support. Oncol. 2011;9:24–31. doi: 10.1016/j.suponc.2010.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b37] Berger AM, Farr LA, Kuhn BR, Fischer P. Agrawal S. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J. Pain Symptom Manage. 2007;33:398–409. doi: 10.1016/j.jpainsymman.2006.09.022. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b38] Berger AM, Kuhn BR, Farr LA, Lynch JC, Agrawal S, Chamberlain J, et al. Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue. Psychooncology. 2009;18:634–646. doi: 10.1002/pon.1438. [DOI] [PubMed] [Google Scholar]

[b39] Berger AM, Kuhn BR, Farr LA, Von Essen SG, Chamberlain J, Lynch JC, et al. One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue. J. Clin. Oncol. 2009;27:6033–6040. doi: 10.1200/JCO.2008.20.8306. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b40] Berger AM, Treat Marunda HA. Agrawal S. Influence of menopausal status on sleep and hot flashes throughout breast cancer adjuvant chemotherapy. J. Obstet. Gynecol. Neonatal. Nurs. 2009;38:353–366. doi: 10.1111/j.1552-6909.2009.01030.x. [DOI] [PubMed] [Google Scholar]

[b41] Berger AM, VonEssen S, Khun BR, Piper BF, Farr L, Agrawal S, et al. Feasibility of a sleep intervention during adjuvant breast cancer chemotherapy. Oncol. Nurs. Forum. 2002;29:1431–1441. doi: 10.1188/02.ONF.1431-1441. [DOI] [PubMed] [Google Scholar]

[b42] Berger AM, VonEssen S, Kuhn BR, Piper BF, Agrawal S, Lynch JC, et al. Adherence, sleep, and fatigue outcomes after adjuvant breast cancer chemotherapy: results of a feasibility intervention study. Oncol. Nurs. Forum. 2003;30:513–522. doi: 10.1188/03.ONF.513-522. [DOI] [PubMed] [Google Scholar]

[b43] Berger AM. Farr L. The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncol. Nurs. Forum. 1999;26:1663–1671. [PubMed] [Google Scholar]

[b44] Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC. Cole SW. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J. Clin. Oncol. 2011;29:3517–3522. doi: 10.1200/JCO.2011.36.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b45] Breen SJ, Baravelli CM, Schofield PE, Jefford M, Yates PM. Aranda SK. Is symptom burden a predictor of anxiety and depression in patients with cancer about to commence chemotherapy? Med. J. Aust. 2009;190(Suppl. 7):S99–S104. doi: 10.5694/j.1326-5377.2009.tb02480.x. [DOI] [PubMed] [Google Scholar]

[b46] Broeckel JA, Jacobsen PB, Horton J, Balducci L. Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J. Clin. Oncol. 1998;16:1689–1696. doi: 10.1200/JCO.1998.16.5.1689. [DOI] [PubMed] [Google Scholar]

[b47] Bruera E, Strasser F, Shen L, Palmer JL, Willey J, Driver LC, et al. The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study. J. Pain Symptom Manage. 2003;26:1049–1054. doi: 10.1016/s0885-3924(03)00332-4. [DOI] [PubMed] [Google Scholar]

[b48] Buffum D, Koetters T, Cho M, Macera L, Paul SM, West C, et al. The effects of pain, gender, and age on sleep/wake and circadian rhythm parameters in oncology patients at the initiation of radiation therapy. J. Pain. 2011;12:390–400. doi: 10.1016/j.jpain.2010.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b49] Byar KL, Berger AM, Bakken SL. Cetak MA. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol. Nurs. Forum. 2006;33:E18–E26. doi: 10.1188/06.ONF.E18-E26. [DOI] [PubMed] [Google Scholar]

[b50] Carpenter JS. Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J. Psychosom. Res. 1998;45:5–13. doi: 10.1016/s0022-3999(97)00298-5. [DOI] [PubMed] [Google Scholar]

[b51] Carson JW, Carson KM, Porter LS, Keefe FJ. Seewaldt VL. Yoga of Awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial. Support. Care Cancer. 2009;17:1301–1309. doi: 10.1007/s00520-009-0587-5. [DOI] [PubMed] [Google Scholar]

[b52] Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, et al. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J. Clin. Oncol. 2011;29:994–1000. doi: 10.1200/JCO.2010.29.8315. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b53] Cohen L, Warneke C, Fouladi RT, Rodriguez MA. Chaoul-Reich A. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer. 2004;100:2253–2260. doi: 10.1002/cncr.20236. [DOI] [PubMed] [Google Scholar]

[b54] Coleman EA, Goodwin JA, Coon SK, Richards K, Enderlin C, Kennedy R, et al. Fatigue, sleep, pain, mood, and performance status in patients with multiple myeloma. Cancer Nurs. 2011;34:219–227. doi: 10.1097/NCC.0b013e3181f9904d. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b55] Costantini C, Ale-Ali A. Helsten T. Sleep aid prescribing practices during neoadjuvant or adjuvant chemotherapy for breast cancer. J. Palliat. Med. 2011;14:563–566. doi: 10.1089/jpm.2010.0465. [DOI] [PubMed] [Google Scholar]

[b56] Couzi RJ, Helzlsouer KJ. Fetting JH. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J. Clin. Oncol. 1995;13:2737–2744. doi: 10.1200/JCO.1995.13.11.2737. [DOI] [PubMed] [Google Scholar]

[b57] Crandall C, Petersen L, Ganz PA. Greendale GA. Association of breast cancer and its therapy with menopause-related symptoms. Menopause. 2004;11:519–530. doi: 10.1097/01.gme.0000117061.40493.ab. [DOI] [PubMed] [Google Scholar]

[b58] Delgado-Guay M, Yennurajalingam S, Parsons H, Palmer JL. Bruera E. Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer. J. Pain Symptom Manage. 2011;41:819–827. doi: 10.1016/j.jpainsymman.2010.07.015. [DOI] [PubMed] [Google Scholar]

[b59] Dirksen SR, Belyea MJ. Epstein DR. Fatigue-based subgroups of breast cancer survivors with insomnia. Cancer Nurs. 2009;32:404–411. doi: 10.1097/NCC.0b013e3181a5d05e. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b60] Dirksen SR, Epstein DR. Hoyt MA. Insomnia, depression, and distress among outpatients with prostate cancer. Appl. Nurs. Res. 2009;22:154–158. doi: 10.1016/j.apnr.2007.09.001. [DOI] [PubMed] [Google Scholar]

[b61] Dodd MJ, Cho MH, Cooper BA. Miaskowski C. The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur. J. Oncol. Nurs. 2010;14:101–110. doi: 10.1016/j.ejon.2009.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b62] Dodd MJ, Miaskowski C. Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol. Nurs. Forum. 2001;28:465–470. [PubMed] [Google Scholar]

[b63] Enderlin CA, Coleman EA, Cole C, Richards KC, Kennedy RL, Goodwin JA, et al. Subjective sleep quality, objective sleep characteristics, insomnia symptom severity, and daytime sleepiness in women aged 50 and older with nonmetastatic breast cancer. Oncol. Nurs. Forum. 2011;38:E314–E325. doi: 10.1188/11.ONF.E314-E325. [DOI] [PubMed] [Google Scholar]

[b64] Epstein DR. Dirksen SR. Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors. Oncol. Nurs. Forum. 2007;34:E51–E59. doi: 10.1188/07.ONF.E51-E59. [DOI] [PubMed] [Google Scholar]

[b65] Fiorentino L, McQuaid JR, Liu L, Natarajan L, He F, Cornejo M, et al. Individual cognitive behavioral therapy for insomnia in breast cancer survivors: a randomized controlled crossover pilot study. Nat. Sci. Sleep. 2010;2:1–8. doi: 10.2147/NSS.S8004. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b66] Flynn KE, Shelby RA, Mitchell SA, Fawzy MR, Hardy NC, Husain AM, et al. Sleep-wake functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)) Psychooncology. 2010;19:1086–1093. doi: 10.1002/pon.1664. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b67] Fox SW, Lyon D. Farace E. Symptom clusters in patients with high-grade glioma. J. Nurs. Scholarsh. 2007;39:61–67. doi: 10.1111/j.1547-5069.2007.00144.x. [DOI] [PubMed] [Google Scholar]

[b68] Francoeur RB. The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation. J. Pain Symptom Manage. 2005;29:130–155. doi: 10.1016/j.jpainsymman.2004.04.014. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b69] Garrett K, Dhruva A, Koetters T, West C, Paul SM, Dunn LB, et al. Differences in sleep disturbance and fatigue between patients with breast and prostate cancer at the initiation of radiation therapy. J. Pain Symptom Manage. 2011;42:239–250. doi: 10.1016/j.jpainsymman.2010.11.010. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b70] Gooneratne NS, Dean GE, Rogers AE, Nkwuo JE, Coyne JC. Kaiser LR. Sleep and quality of life in long-term lung cancer survivors. Lung Cancer. 2007;58:403–410. doi: 10.1016/j.lungcan.2007.07.011. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b71] Grutsch JF, Ferrans C, Wood PA, Du-Quiton J, Quiton DF, Reynolds JL, et al. The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. BMC Cancer. 2011;11:1–13. doi: 10.1186/1471-2407-11-193. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b72] Hanisch LJ, Gooneratne NS, Soin K, Gehrman PR, Vaughn DJ. Coyne JC. Sleep and daily functioning during androgen deprivation therapy for prostate cancer. Eur. J. Cancer Care (Engl.) 2011;20:549–554. doi: 10.1111/j.1365-2354.2010.01226.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b73] Hickey M, Emery LI, Gregson J, Doherty DA. Saunders CM. The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care. Menopause. 2010;17:727–733. doi: 10.1097/gme.0b013e3181d672f6. [DOI] [PubMed] [Google Scholar]

[b74] Hoffman AJ, Given BA, von Eye A, Gift AG. Given CW. Relationships among pain, fatigue, insomnia, and gender in persons with lung cancer. Oncol. Nurs. Forum. 2007;34:785–792. doi: 10.1188/07.ONF.785-792. [DOI] [PubMed] [Google Scholar]

[b75] Hoyt MA, Thomas KS, Epstein DR. Dirksen SR. Coping style and sleep quality in men with cancer. Ann. Behav. Med. 2009;37:88–93. doi: 10.1007/s12160-009-9079-6. [DOI] [PubMed] [Google Scholar]

[b76] Janz NK, Mujahid M, Chung LK, Lantz PM, Hawley ST, Morrow M, et al. Symptom experience and quality of life of women following breast cancer treatment. J. Womens Health. 2007;16:1348–1361. doi: 10.1089/jwh.2006.0255. [DOI] [PubMed] [Google Scholar]

[b77] Joffe H, Partridge A, Giobbie-Hurder A, Li X, Habin K, Goss P, et al. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. Menopause. 2010;17:908–916. doi: 10.1097/gme.0b013e3181dbee1b. [DOI] [PubMed] [Google Scholar]

[b78] Kaye J, Kaye K. Madow L. Sleep patterns in patients with cancer and patients with cardiac disease. J. Psychol. 1983;114(1st Half):107–113. doi: 10.1080/00223980.1983.9915403. [DOI] [PubMed] [Google Scholar]

[b79] Knobf MT. The menopausal symptom experience in young mid-life women with breast cancer. Cancer Nurs. 2001;24:201–210. [PubMed] [Google Scholar]

[b80] Kozachik SL. Bandeen-Roche K. Predictors of patterns of pain, fatigue, and insomnia during the first year after a cancer diagnosis in the elderly. Cancer Nurs. 2008;31:334–344. doi: 10.1097/01.NCC.0000305769.27227.67. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b81] Kwekkeboom KL, Abbott-Anderson K. Wanta B. Feasibility of a patient-controlled cognitive-behavioral intervention for pain, fatigue, and sleep disturbance in cancer. Oncol. Nurs. Forum. 2010;37:E151–E159. doi: 10.1188/10.ONF.E151-E159. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b82] Lamb MA. The sleeping patterns of patients with malignant and nonmalignant diseases. Cancer Nurs. 1982;5:389–396. [PubMed] [Google Scholar]

[b83] Lipov EG, Joshi JR, Sanders S, Wilcox K, Lipov S, Xie H, et al. Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study. Lancet Oncol. 2008;9:523–532. doi: 10.1016/S1470-2045(08)70131-1. [DOI] [PubMed] [Google Scholar]

[b84] Lis CG, Gupta D. Grutsch JF. The relationship between insomnia and patient satisfaction with quality of life in cancer. Support. Care Cancer. 2008;16:261–266. doi: 10.1007/s00520-007-0314-z. [DOI] [PubMed] [Google Scholar]

[b85] Liu L, Fiorentino L, Natarajan L, Parker BA, Mills PJ, Sadler GR, et al. Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psychooncology. 2009;18:187–194. doi: 10.1002/pon.1412. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b86] Matthews EE, Schmiege SJ, Cook PF. Sousa KH. Breast cancer and symptom clusters during radiotherapy. Cancer Nurs. 2012;35:E1–E11. doi: 10.1097/NCC.0b013e3182277222. [DOI] [PubMed] [Google Scholar]

[b87] McChargue DE, Sankaranarayanan J, Visovsky CG, Matthews EE, Highland KB. Berger AM. Predictors of adherence to a behavioral therapy sleep intervention during breast cancer chemotherapy. Support. Care Cancer. 2012;20:245–252. doi: 10.1007/s00520-010-1060-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b88] McMillan SC, Tittle M, Hagan S. Laughlin J. Management of pain and pain-related symptoms in hospitalized veterans with cancer. Cancer Nurs. 2000;23:327–336. doi: 10.1097/00002820-200010000-00001. [DOI] [PubMed] [Google Scholar]

[b89] McMillan SC, Tofthagen C. Morgan MA. Relationships among pain, sleep disturbances, and depressive symptoms in outpatients from a comprehensive cancer center. Oncol. Nurs. Forum. 2008;35:603–611. doi: 10.1188/08.ONF.603-611. [DOI] [PubMed] [Google Scholar]

[b90] Miaskowski C, Paul SM, Cooper BA, Lee K, Dodd M, West C, et al. Predictors of the trajectories of self-reported sleep disturbance in men with prostate cancer during and following radiation therapy. Sleep. 2011;34:171–179. doi: 10.1093/sleep/34.2.171. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b91] Moore TA, Berger AM. Dizona P. Sleep aid use during and following breast cancer adjuvant chemotherapy. Psychooncology. 2011;20:321–325. doi: 10.1002/pon.1756. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b92] Mosher CE. Duhamel KN. An examination of distress, sleep, and fatigue in metastatic breast cancer patients. Psychooncology. 2012;21:100–107. doi: 10.1002/pon.1873. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b93] Mulrooney DA, Ness KK, Neglia JP, Whitton JA, Green DM, Zeltzer LK, et al. Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS) Sleep. 2008;31:271–281. doi: 10.1093/sleep/31.2.271. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b94] Otte JL, Carpenter JS, Russell KM, Bigatti S. Champion VL. Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. J. Pain Symptom Manage. 2010;39:535–547. doi: 10.1016/j.jpainsymman.2009.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b95] Owen DC, Parker KP. McGuire DB. Comparison of subjective sleep quality in patients with cancer and healthy subjects. Oncol. Nurs. Forum. 1999;26:1649–1651. [PubMed] [Google Scholar]

[b96] Palesh O, Zeitzer JM, Conrad A, Giese-Davis J, Mustian KM, Popek V, et al. Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer. J. Clin. Sleep Med. 2008;4:441–449. [PMC free article] [PubMed] [Google Scholar]

[b97] Palesh OG, Collie K, Batiuchok D, Tilston J, Koopman C, Perlis ML, et al. A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol. Psychol. 2007;75:37–44. doi: 10.1016/j.biopsycho.2006.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b98] Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J. Clin. Oncol. 2010;28:292–298. doi: 10.1200/JCO.2009.22.5011. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b99] Parker KP, Bliwise DL, Ribeiro M, Jain SR, Vena CI, Kohles-Baker MK, et al. Sleep/wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J. Clin. Oncol. 2008;26:2464–2472. doi: 10.1200/JCO.2007.12.2135. [DOI] [PubMed] [Google Scholar]

[b100] Passik SD, Whitcomb LA, Kirsh KL. Theobald DE. An unsuccessful attempt to develop a single-item screen for insomnia in cancer patients. J. Pain Symptom Manage. 2003;25:284–287. doi: 10.1016/s0885-3924(02)00692-9. [DOI] [PubMed] [Google Scholar]

[b101] Payne J, Piper B, Rabinowitz I. Zimmerman B. Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study. Oncol. Nurs. Forum. 2006;33:775–783. doi: 10.1188/06.ONF.775-783. [DOI] [PubMed] [Google Scholar]

[b102] Payne JK, Held J, Thorpe J. Shaw H. Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. Oncol. Nurs. Forum. 2008;35:635–642. doi: 10.1188/08.ONF.635-642. [DOI] [PubMed] [Google Scholar]

[b103] Phillips KM, Jim HS, Donovan KA, Pinder-Schenck MC. Jacobsen PB. Characteristics and correlates of sleep disturbances in cancer patients. Support. Care Cancer. 2012;20:357–365. doi: 10.1007/s00520-011-1106-z. [DOI] [PubMed] [Google Scholar]

[b104] Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Coyle N, et al. Symptom prevalence, characteristics and distress in a cancer population. Qual. Life Res. 1994;3:183–189. doi: 10.1007/BF00435383. [DOI] [PubMed] [Google Scholar]

[b105] Redeker NS, Lev EL. Ruggiero J. Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch. Inq. Nurs. Pract. 2000;14:275–290. discussion 91-8. [PubMed] [Google Scholar]

[b106] Rissling MB, Liu L, Natarajan L, He F. Ancoli-Israel S. Relationship of menopausal status and climacteric symptoms to sleep in women undergoing chemotherapy. Support. Care Cancer. 2011;19:1107–1115. doi: 10.1007/s00520-010-0914-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b107] Rogers LQ, Courneya KS, Robbins KT, Rao K, Malone J, Seiz A, et al. Factors associated with fatigue, sleep, and cognitive function among patients with head and neck cancer. Head Neck. 2008;30:1310–1317. doi: 10.1002/hed.20873. [DOI] [PubMed] [Google Scholar]

[b108] Rumble ME, Keefe FJ, Edinger JD, Affleck G, Marcom PK. Shaw HS. Contribution of cancer symptoms, dysfunctional sleep related thoughts, and sleep inhibitory behaviors to the insomnia process in breast cancer survivors: a daily process analysis. Sleep. 2010;33:1501–1509. doi: 10.1093/sleep/33.11.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b109] Rumble ME, Keefe FJ, Edinger JD, Porter LS. Garst JL. A pilot study investigating the utility of the cognitive-behavioral model of insomnia in early-stage lung cancer patients. J. Pain Symptom Manage. 2005;30:160–169. doi: 10.1016/j.jpainsymman.2005.02.013. [DOI] [PubMed] [Google Scholar]

[b110] Sarna L. Correlates of symptom distress in women with lung cancer. Cancer Pract. 1993;1:21–28. [PubMed] [Google Scholar]

[b111] Schlairet MC. Needs of older cancer survivors in a community cancer care setting. J. Gerontol. Nurs. 2011;37:36–41. doi: 10.3928/00989134-20100730-05. [DOI] [PubMed] [Google Scholar]

[b112] Schultz PN, Klein MJ, Beck ML, Stava C. Sellin RV. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors. J. Clin. Nurs. 2005;14:204–211. doi: 10.1111/j.1365-2702.2004.01030.x. [DOI] [PubMed] [Google Scholar]

[b113] Sherwood P, Given BA, Given CW, Champion VL, Doorenbos AZ, Azzouz F, et al. A cognitive behavioral intervention for symptom management in patients with advanced cancer. Oncol. Nurs. Forum. 2005;32:1190–1198. doi: 10.1188/05.ONF.1190-1198. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b114] Shuman AG, Duffy SA, Ronis DL, Garetz SL, McLean SA, Fowler KE, et al. Predictors of poor sleep quality among head and neck cancer patients. Laryngoscope. 2010;120:1166–1172. doi: 10.1002/lary.20924. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b115] Silberfarb PM, Hauri PJ, Oxman TE. Schnurr P. Assessment of sleep in patients with lung cancer and breast cancer. J. Clin. Oncol. 1993;11:997–1004. doi: 10.1200/JCO.1993.11.5.997. [DOI] [PubMed] [Google Scholar]

[b116] Snyder CF, Garrett-Mayer E, Brahmer JR, Carducci MA, Pili R, Stearns V, et al. Symptoms, supportive care needs, and function in cancer patients: how are they related? Qual. Life Res. 2008;17:665–677. doi: 10.1007/s11136-008-9331-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b117] Sprod LK, Palesh OG, Janelsins MC, Peppone LJ, Heckler CE, Adams MJ, et al. Exercise, sleep quality, and mediators of sleep in breast and prostate cancer patients receiving radiation therapy. Community Oncol. 2010;7:463–471. doi: 10.1016/s1548-5315(11)70427-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b118] Tatrow K, Montgomery GH, Avellino M. Bovbjerg DH. Activity and sleep contribute to levels of anticipatory distress in breast surgery patients. Behav. Med. 2004;30:85–91. doi: 10.3200/BMED.30.2.85-94. [DOI] [PubMed] [Google Scholar]

[b119] Taylor TR, Huntley ED, Makambi K, Sween J, Adams-Campbell LL, Frederick W, et al. Understanding sleep disturbances in African-American breast cancer survivors: a pilot study. Psychooncology. 2012;21:896–902. doi: 10.1002/pon.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b120] Thomas KS, Bower J, Hoyt MA. Sepah S. Disrupted sleep in breast and prostate cancer patients undergoing radiation therapy: the role of coping processes. Psychooncology. 2010;19:767–776. doi: 10.1002/pon.1639. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b121] Sheely LC. Sleep disturbances in hospitalized patients with cancer. Oncol. Nurs. Forum. 1996;23:109–111. [PubMed] [Google Scholar]

[b122] Van Onselen C, Dunn LB, Lee K, Dodd M, Koetters T, West C, et al. Relationship between mood disturbance and sleep quality in oncology outpatients at the initiation of radiation therapy. Eur. J. Oncol. Nurs. 2010;14:373–379. doi: 10.1016/j.ejon.2009.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b123] Vargas S, Wohlgemuth WK, Antoni MH, Lechner SC, Holley HA. Carver CS. Sleep dysfunction and psychosocial adaptation among women undergoing treatment for non-metastatic breast cancer. Psychooncology. 2010;19:669–673. doi: 10.1002/pon.1603. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b124] Weitzner MA, Moncello J, Jacobsen PB. Minton S. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J. Pain Symptom Manage. 2002;23:337–345. doi: 10.1016/s0885-3924(02)00379-2. [DOI] [PubMed] [Google Scholar]

[b125] Williams SA. Schreier AM. The role of education in managing fatigue, anxiety, and sleep disorders in women undergoing chemotherapy for breast cancer. Appl. Nurs. Res. 2005;18:138–147. doi: 10.1016/j.apnr.2004.08.005. [DOI] [PubMed] [Google Scholar]

[b126] Wright CE, Bovbjerg DH, Montgomery GH, Weltz C, Goldfarb A, Pace B, et al. Disrupted sleep the night before breast surgery is associated with increased postoperative pain. J. Pain Symptom Manage. 2009;37:352–362. doi: 10.1016/j.jpainsymman.2008.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b127] Young-McCaughan S, Mays MZ, Arzola SM, Yoder LH, Dramiga SA, Leclerc KM, et al. Research and commentary: change in exercise tolerance, activity and sleep patterns, and quality of life in patients with cancer participating in a structured exercise program. Oncol. Nurs. Forum. 2003;30:441–454. doi: 10.1188/03.ONF.441-454. [DOI] [PubMed] [Google Scholar]

[b128] Cannici J, Malcolm R. Peek LA. Treatment of insomnia in cancer patients using muscle relaxation training. J. Behav. Ther. Exp. Psychiatry. 1983;14:251–256. doi: 10.1016/0005-7916(83)90056-3. [DOI] [PubMed] [Google Scholar]

[b129] Merriman JD, Dodd M, Lee K, Paul SM, Cooper BA, Aouizerat BE, et al. Differences in self-reported attentional fatigue between patients with breast and prostate cancer at the initiation of radiation therapy. Cancer Nurs. 2011;34:345–353. doi: 10.1097/NCC.0b013e318202520a. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b130] Miaskowski C, Lee K, Dunn L, Dodd M, Aouizerat BE, West C, et al. Sleep-wake circadian activity rhythm parameters and fatigue in oncology patients before the initiation of radiation therapy. Cancer Nurs. 2011;34:255–268. doi: 10.1097/NCC.0b013e3181f65d9b. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b131] Otte JL, Carpenter JS, Zhong X. Johnstone PA. Feasibility study of acupuncture for reducing sleep disturbances and hot flashes in postmenopausal breast cancer survivors. Clin. Nurse Spec. 2011;25:228–236. doi: 10.1097/NUR.0b013e318229950b. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b132] Otte JL, Payne JK. Carpenter JS. Nighttime variability in wrist actigraphy. J. Nurs. Meas. 2011;19:105–114. doi: 10.1891/1061-3749.19.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b133] Sandadi S, Frasure HE, Broderick MJ, Waggoner SE, Miller JA. von Gruenigen VE. The effect of sleep disturbance on quality of life in women with ovarian cancer. Gynecol. Oncol. 2011;123:351–355. doi: 10.1016/j.ygyno.2011.07.028. [DOI] [PubMed] [Google Scholar]

[b134] Shapiro SL, Bootzin RR, Figueredo AJ, Lopez AM. Schwartz GE. The efficacy of mindfulness-based stress reduction in the treatment of sleep disturbance in women with breast cancer: an exploratory study. J. Psychosom. Res. 2003;54:85–91. doi: 10.1016/s0022-3999(02)00546-9. [DOI] [PubMed] [Google Scholar]

[b135] Silberfarb PM, Hauri PJ, Oxman TE. Lash S. Insomnia in cancer patients. Soc. Sci. Med. 1985;20:849–850. doi: 10.1016/0277-9536(85)90340-5. [DOI] [PubMed] [Google Scholar]

[b136] Wright CE, Schnur JB, Montgomery GH. Bovbjerg DH. Psychological factors associated with poor sleep prior to breast surgery: an exploratory study. Behav. Med. 2010;36:85–91. doi: 10.1080/08964280903521305. [DOI] [PubMed] [Google Scholar]

[b137] Wu HS, Davis JE, Padiyar JP. Yarandi H. A comparison of disrupted sleep patterns in women with cancer-related fatigue and postmenopausal women without cancer. Eur. J. Oncol. Nurs. 2011;15:318–324. doi: 10.1016/j.ejon.2010.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b138] Berger AM, Hertzog M, Geary CR, Fischer P. Farr L. Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors. J. Cancer Surviv. 2012;6:305–314. doi: 10.1007/s11764-012-0218-x. [DOI] [PubMed] [Google Scholar]

[b139] Berger AM, Visovsky C, Hertzog M, Holtz S. Loberiza FR., Jr Usual and worst symptom severity and interference with function in breast cancer survivors. J. Support. Oncol. 2012;10:112–118. doi: 10.1016/j.suponc.2011.11.001. [DOI] [PubMed] [Google Scholar]

[b140] Berger AM, Wielgus K, Hertzog M, Fischer P. Farr L. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. J. Support. Oncol. 2010;18:105–114. doi: 10.1007/s00520-009-0636-0. [DOI] [PubMed] [Google Scholar]

[b141] Bower JE, Garet D, Sternlieb B, Ganz PA, Irwin MR, Olmstead R, et al. Yoga for persistent fatigue in breast cancer survivors: a randomized controlled trial. Cancer. 2012;118:3766–3775. doi: 10.1002/cncr.26702. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b142] Boyd AD, Brown D, Henrickson C, Hampton J, Zhu B, Almani F, et al. Screening for depression, sleep-related disturbances, and anxiety in patients with adenocarcinoma of the pancreas: a preliminary study. ScientificWorldJournal. 2012;2012:1–6. doi: 10.1100/2012/650707. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b143] Brant JM, Beck SL, Dudley WN, Cobb P, Pepper G. Miaskowski C. Symptom trajectories during chemotherapy in outpatients with lung cancer colorectal cancer, or lymphoma. Eur. J. Oncol. Nurs. 2011;15:470–477. doi: 10.1016/j.ejon.2010.12.002. [DOI] [PubMed] [Google Scholar]

[b144] Brown JK, Cooley ME, Chernecky C. Sarna L. A symptom cluster and sentinel symptom experienced by women with lung cancer. Oncol. Nurs. Forum. 2011;38:E425–E435. doi: 10.1188/11.ONF.E425-E435. [DOI] [PubMed] [Google Scholar]

[b145] Cho MH, Dodd MJ, Cooper BA. Miaskowski C. Comparisons of exercise dose and symptom severity between exercisers and nonexercisers in women during and after cancer treatment. J. Pain Symptom Manage. 2012;43:842–854. doi: 10.1016/j.jpainsymman.2011.05.016. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b146] Clevenger L, Schrepf A, Christensen D, DeGeest K, Bender D, Ahmed A, et al. Sleep disturbance, cytokines, and fatigue in women with ovarian cancer. Brain Behav. Immun. 2012;26:1037–1044. doi: 10.1016/j.bbi.2012.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b147] Coleman EA, Goodwin JA, Kennedy R, Coon SK, Richards K, Enderlin C, et al. Effects of exercise on fatigue, sleep, and performance: a randomized trial. Oncol. Nurs. Forum. 2012;39:468–477. doi: 10.1188/12.ONF.468-477. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b148] Dedert E, Lush E, Chagpar A, Dhabhar FS, Segerstrom SC, Spiegel D, et al. Stress, coping, and circadian disruption among women awaiting breast cancer surgery. Ann. Behav. Med. 2012;44:10–20. doi: 10.1007/s12160-012-9352-y. [DOI] [PubMed] [Google Scholar]

[b149] Dhruva A, Miaskowski C, Abrams D, Acree M, Cooper B, Goodman S, et al. Yoga breathing for cancer chemotherapy-associated symptoms and quality of life: results of a pilot randomized controlled trial. J. Altern. Complement. Med. 2012;18:473–479. doi: 10.1089/acm.2011.0555. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b150] Jim HS, Small B, Faul LA, Franzen J, Apte S. Jacobsen PB. Fatigue, depression, sleep, and activity during chemotherapy: daily and intraday variation and relationships among symptom changes. Ann. Behav. Med. 2011;42:321–333. doi: 10.1007/s12160-011-9294-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b151] Dhruva A, Paul SM, Cooper BA, Lee K, West C, Aouizerat BE, et al. A longitudinal study of measures of objective and subjective sleep disturbance in patients with breast cancer before, during, and after radiation therapy. J. Pain Symptom Manage. 2012;44:215–228. doi: 10.1016/j.jpainsymman.2011.08.010. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b152] Dickerson SS, Sabbah EA, Ziegler P, Chen H, Steinbrenner LM. Dean G. The experience of a diagnosis of advanced lung cancer: sleep is not a priority when living my life. Oncol. Nurs. Forum. 2012;39:492–499. doi: 10.1188/12.ONF.492-499. [DOI] [PubMed] [Google Scholar]

[b153] Dimsdale JE, Ball ED, Carrier E, Wallace M, Holman P, Mulroney C, et al. Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies. Support. Care Cancer. 2011;19:2015–2020. doi: 10.1007/s00520-010-1052-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b154] Gallicchio L, MacDonald R, Wood B, Rushovich E. Helzlsouer KJ. Menopausal-type symptoms among breast cancer patients on aromatase inhibitor therapy. Climacteric. 2012;15:339–349. doi: 10.3109/13697137.2011.620658. [DOI] [PubMed] [Google Scholar]

[b155] Gerber LH, Stout N, McGarvey C, Soballe P, Shieh CY, Diao G, et al. Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support. Care Cancer. 2011;19:1581–1591. doi: 10.1007/s00520-010-0986-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b156] Carpenter JS, Burns DS, Wu J, Otte JL, Schneider B, Ryker K, et al. Paced respiration for vasomotor and other menopausal symptoms: a randomized, controlled trial. J. Gen. Intern. Med. 2013;28:193–200. doi: 10.1007/s11606-012-2202-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b157] Jensen MP, Gralow JR, Braden A, Gertz KJ, Fann JR. Syrjala KL. Hypnosis for symptom management in women with breast cancer: a pilot study. Int. J. Clin. Exp. Hypn. 2012;60:135–159. doi: 10.1080/00207144.2012.648057. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b158] Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, et al. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav. Immun. 2012;26:706–713. doi: 10.1016/j.bbi.2012.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b159] Liu L, Rissling M, Natarajan L, Fiorentino L, Mills PJ, Dimsdale JE, et al. The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy. Sleep. 2012;35:237–245. doi: 10.5665/sleep.1630. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b160] Matthews EE, Schmiege SJ, Cook PF, Berger AM. Aloia MS. Adherence to cognitive behavioral therapy for insomnia (CBTI) among women following primary breast cancer treatment: a pilot study. Behav. Sleep Med. 2012;10:217–229. doi: 10.1080/15402002.2012.666220. [DOI] [PubMed] [Google Scholar]

[b161] Ritterband LM, Bailey ET, Thorndike FP, Lord HR, Farrell-Carnahan L. Baum LD. Initial evaluation of an Internet intervention to improve the sleep of cancer survivors with insomnia. Psychooncology. 2012;21:695–705. doi: 10.1002/pon.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b162] Roscoe JA, Perlis ML, Pigeon WR, O'Neill KH, Heckler CE, Matteson-Rusby SE, et al. Few changes observed in polysomnographic-assessed sleep before and after completion of chemotherapy. J. Psychosom. Res. 2011;71:423–428. doi: 10.1016/j.jpsychores.2011.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b163] Carlson LE, Campbell TS, Garland SN. Grossman P. Associations among salivary cortisol, melatonin, catecholamines, sleep quality and stress in women with breast cancer and healthy controls. J. Behav. Med. 2007;30:45–58. doi: 10.1007/s10865-006-9082-3. [DOI] [PubMed] [Google Scholar]

[b164] Carlson LE, Speca M, Patel KD. Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004;29:448–474. doi: 10.1016/s0306-4530(03)00054-4. [DOI] [PubMed] [Google Scholar]

[b165] Casault L, Savard J, Ivers H, Savard MH. Simard S. Utilization of hypnotic medication in the context of cancer: predictors and frequency of use. Support. Care Cancer. 2012;20:1203–1210. doi: 10.1007/s00520-011-1199-4. [DOI] [PubMed] [Google Scholar]

[b166] Davidson JR, Feldman-Stewart D, Brennenstuhl S. Ram S. How to provide insomnia interventions to people with cancer: insights from patients. Psychooncology. 2007;16:1028–1038. doi: 10.1002/pon.1183. [DOI] [PubMed] [Google Scholar]

[b167] Davidson JR, Waisberg JL, Brundage MD. MacLean AW. Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors. Psychooncology. 2001;10:389–397. doi: 10.1002/pon.525. [DOI] [PubMed] [Google Scholar]

[b168] Hadi S, Fan G, Hird AE, Kirou-Mauro A, Filipczak LA. Chow E. Symptom clusters in patients with cancer with metastatic bone pain. J. Palliat. Med. 2008;11:591–600. doi: 10.1089/jpm.2007.0145. [DOI] [PubMed] [Google Scholar]

[b169] Hadi S, Zhang L, Hird A, de Sa E. Chow E. Validation of symptom clusters in patients with metastatic bone pain. Curr. Oncol. 2008;15:211–218. doi: 10.3747/co.v15i5.289. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b170] Khan L, Uy C, Nguyen J, Chow E, Zhang L, Zeng L, et al. Self-reported rates of sleep disturbance in patients with symptomatic bone metastases attending an outpatient radiotherapy clinic. J. Palliat. Med. 2011;14:708–714. doi: 10.1089/jpm.2010.0491. [DOI] [PubMed] [Google Scholar]

[b171] Payne RJ, Hier MP, Kost KM, Black MJ, Zeitouni AG, Frenkiel S, et al. High prevalence of obstructive sleep apnea among patients with head and neck cancer. J. Otolaryngol. 2005;34:304–311. doi: 10.2310/7070.2005.34502. [DOI] [PubMed] [Google Scholar]

[b172] Quesnel C, Savard J, Simard S, Ivers H. Morin CM. Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. J. Consult. Clin. Psychol. 2003;71:189–200. [PubMed] [Google Scholar]

[b173] Savard J, Davidson JR, Ivers H, Quesnel C, Rioux D, Dupere V, et al. The association between nocturnal hot flashes and sleep in breast cancer survivors. J. Pain Symptom Manage. 2004;27:513–522. doi: 10.1016/j.jpainsymman.2003.10.013. [DOI] [PubMed] [Google Scholar]

[b174] Savard J, Ivers H, Villa J, Caplette-Gingras A. Morin CM. Natural course of insomnia comorbid with cancer: an 18-month longitudinal study. J. Clin. Oncol. 2011;29:3580–3586. doi: 10.1200/JCO.2010.33.2247. [DOI] [PubMed] [Google Scholar]

[b175] Savard J, Liu L, Natarajan L, Rissling MB, Neikrug AB, He F, et al. Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep. 2009;32:1155–1160. doi: 10.1093/sleep/32.9.1155. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b176] Savard J, Simard S, Blanchet J, Ivers H. Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 2001;24:583–590. doi: 10.1093/sleep/24.5.583. [DOI] [PubMed] [Google Scholar]

[b177] Savard J, Simard S, Hervouet S, Ivers H, Lacombe L. Fradet Y. Insomnia in men treated with radical prostatectomy for prostate cancer. Psychooncology. 2005;14:147–156. doi: 10.1002/pon.830. [DOI] [PubMed] [Google Scholar]

[b178] Savard J, Simard S, Ivers H. Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: immunologic effects. J. Clin. Oncol. 2005;23:6097–6106. doi: 10.1200/JCO.2005.12.513. [DOI] [PubMed] [Google Scholar]

[b179] Savard J, Simard S, Ivers H. Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J. Clin. Oncol. 2005;23:6083–6096. doi: 10.1200/JCO.2005.09.548. [DOI] [PubMed] [Google Scholar]

[b180] Savard J, Villa J, Ivers H, Simard S. Morin CM. Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J. Clin. Oncol. 2009;27:5233–5239. doi: 10.1200/JCO.2008.21.6333. [DOI] [PubMed] [Google Scholar]

[b181] Savard J, Villa J, Simard S, Ivers H. Morin CM. Feasibility of a self-help treatment for insomnia comorbid with cancer. Psychooncology. 2011;20:1013–1019. doi: 10.1002/pon.1818. [DOI] [PubMed] [Google Scholar]

[b182] Savard MH, Savard J, Simard S. Ivers H. Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncology. 2004;14:429–441. doi: 10.1002/pon.860. [DOI] [PubMed] [Google Scholar]

[b183] Savard MH, Savard J, Trudel-Fitzgerald C, Ivers H. Quesnel C. Changes in self-reported hot flashes and their association with concurrent changes in insomnia symptoms among women with breast cancer. Menopause. 2011;18:985–993. doi: 10.1097/gme.0b013e31820db6a1. [DOI] [PubMed] [Google Scholar]

[b184] Sela RA, Watanabe S. Nekolaichuk CL. Sleep disturbances in palliative cancer patients attending a pain and symptom control clinic. Palliat. Support. Care. 2005;3:23–31. doi: 10.1017/s1478951505050042. [DOI] [PubMed] [Google Scholar]

[b185] Stevinson C, Steed H, Faught W, Tonkin K, Vallance JK, Ladha AB, et al. Physical activity in ovarian cancer survivors: associations with fatigue, sleep, and psychosocial functioning. Int. J. Gynecol. Cancer. 2009;19:73–78. doi: 10.1111/IGC.0b013e31819902ec. [DOI] [PubMed] [Google Scholar]

[b186] Tremblay V, Savard J. Ivers H. Predictors of the effect of cognitive behavioral therapy for chronic insomnia comorbid with breast cancer. J. Consult. Clin. Psychol. 2009;77:742–750. doi: 10.1037/a0015492. [DOI] [PubMed] [Google Scholar]

[b187] Cerrone R, Giani L, Galbiati B, Messina G, Casiraghi M, Proserpio E, et al. Efficacy of HT 7 point acupressure stimulation in the treatment of insomnia in cancer patients and in patients suffering from disorders other than cancer. Minerva Med. 2008;99:535–537. [PubMed] [Google Scholar]

[b188] Dahl AA, Nesvold IL, Reinertsen KV. Fossa SD. Arm/shoulder problems and insomnia symptoms in breast cancer survivors: cross-sectional, controlled and longitudinal observations. Sleep Med. 2011;12:584–590. doi: 10.1016/j.sleep.2011.01.011. [DOI] [PubMed] [Google Scholar]

[b189] Dominguez-Ortega L, Cubedo-Cervera R, Cortes-Funes H. Diaz-Gallego E. Sleep protects against chemotherapy induced emesis. Cancer. 1996;77:1566–1570. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1566::AID-CNCR21>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]

[b190] Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J. Clin. Oncol. 2008;26:1–9. doi: 10.1200/JCO.2007.13.9006. [DOI] [PubMed] [Google Scholar]

[b191] Fernandes R, Stone P, Andrews P, Morgan R. Sharma S. Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: evaluation of diagnostic criteria for cancer-related fatigue. J. Pain Symptom Manage. 2006;32:245–254. doi: 10.1016/j.jpainsymman.2006.03.014. [DOI] [PubMed] [Google Scholar]

[b192] Fleming L, Gillespie S. Espie CA. The development and impact of insomnia on cancer survivors: a qualitative analysis. Psychooncology. 2010;19:991–996. doi: 10.1002/pon.1652. [DOI] [PubMed] [Google Scholar]

[b193] Frisk J, Kallstrom AC, Wall N, Fredrikson M. Hammar M. Acupuncture improves health-related quality-of-life (HRQoL) and sleep in women with breast cancer and hot flushes. Support. Care Cancer. 2012;20:715–724. doi: 10.1007/s00520-011-1134-8. [DOI] [PubMed] [Google Scholar]

[b194] Gibbins J, McCoubrie R, Kendrick AH, Senior-Smith G, Davies AN. Hanks GW. Sleep-wake disturbances in patients with advanced cancer and their family carers. J. Pain Symptom Manage. 2009;38:860–870. doi: 10.1016/j.jpainsymman.2009.04.025. [DOI] [PubMed] [Google Scholar]

[b195] Goedendorp MM, Gielissen MF, Verhagen CA, Peters ME. Bleijenberg G. Severe fatigue and related factors in cancer patients before the initiation of treatment. Br. J. Cancer. 2008;99:1408–1414. doi: 10.1038/sj.bjc.6604739. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b196] Gogenur I, Wildschiotz G. Rosenberg J. Circadian distribution of sleep phases after major abdominal surgery. Br. J. Anaesth. 2008;100:45–49. doi: 10.1093/bja/aem340. [DOI] [PubMed] [Google Scholar]

[b197] Henoch I, Ploner A. Tishelman C. Increasing stringency in symptom cluster research: a methodological exploration of symptom clusters in patients with inoperable lung cancer. Oncol. Nurs. Forum. 2009;36:E282–E292. doi: 10.1188/09.ONF.E283-E292. [DOI] [PubMed] [Google Scholar]

[b198] Hoekstra J, Vernooij-Dassen MJ, de Vos R. Bindels PJ. The added value of assessing the ‘most troublesome’ symptom among patients with cancer in the palliative phase. Patient Educ. Couns. 2007;65:223–229. doi: 10.1016/j.pec.2006.08.001. [DOI] [PubMed] [Google Scholar]

[b199] Hoijer U, Ejnell H. Hedner J. Obstructive sleep apnea in patients with pharyngeal tumours. Acta Otolaryngol. 1992;112:138–143. doi: 10.3109/00016489209100795. [DOI] [PubMed] [Google Scholar]

[b200] Hunter MS, Coventry S, Hamed H, Fentiman I. Grunfeld EA. Evaluation of a group cognitive behavioural intervention for women suffering from menopausal symptoms following breast cancer treatment. Psychooncology. 2009;18:560–563. doi: 10.1002/pon.1414. [DOI] [PubMed] [Google Scholar]

[b201] Hunter MS, Coventry S, Mendes N. Grunfeld EA. Menopausal symptoms following breast cancer treatment: a qualitative investigation of cognitive and behavioural responses. Maturitas. 2009;63:336–340. doi: 10.1016/j.maturitas.2009.06.003. [DOI] [PubMed] [Google Scholar]

[b202] Hunter MS, Grunfeld EA, Mittal S, Sikka P, Ramirez AJ, Fentiman I, et al. Menopausal symptoms in women with breast cancer: prevalence and treatment preferences. Psychooncology. 2004;13:769–778. doi: 10.1002/pon.793. [DOI] [PubMed] [Google Scholar]

[b203] Jimenez A, Madero R, Alonso A, Martinez-Marin V, Vilches Y, Martinez B, et al. Symptom clusters in advanced cancer. J. Pain Symptom Manage. 2011;42:24–31. doi: 10.1016/j.jpainsymman.2010.10.266. [DOI] [PubMed] [Google Scholar]

[b204] Le Guen Y, Gagnadoux F, Hureaux J, Jeanfaivre T, Meslier N, Racineux JL, et al. Sleep disturbances and impaired daytime functioning in outpatients with newly diagnosed lung cancer. Lung Cancer. 2007;58:139–143. doi: 10.1016/j.lungcan.2007.05.021. [DOI] [PubMed] [Google Scholar]

[b205] Levin RD, Daehler MA, Grutsch JF, Quiton J, Lis CG, Peterson C, et al. Circadian function in patients with advanced non-small-cell lung cancer. Br. J. Cancer. 2005;93:1202–1208. doi: 10.1038/sj.bjc.6602859. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b206] Mercadante S, Girelli D. Casuccio A. Sleep disorders in advanced cancer patients: prevalence and factors associated. Support. Care Cancer. 2004;12:355–359. doi: 10.1007/s00520-004-0623-4. [DOI] [PubMed] [Google Scholar]

[b207] Mormont MC, Waterhouse J, Bleuzen P, Giacchetti S, Jami A, Bogdan A, et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin. Cancer Res. 2000;6:3038–3045. [PubMed] [Google Scholar]

[b208] Munro AJ. Potter S. A quantitative approach to the distress caused by symptoms in patients treated with radical radiotherapy. Br. J. Cancer. 1996;74:640–647. doi: 10.1038/bjc.1996.414. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b209] Nesse W, Hoekema A, Stegenga B, van der Hoeven JH, de Bont LG. Roodenburg JL. Prevalence of obstructive sleep apnoea following head and neck cancer treatment: a cross-sectional study. Oral Oncol. 2006;42:108–114. doi: 10.1016/j.oraloncology.2005.06.022. [DOI] [PubMed] [Google Scholar]

[b210] Pasquini M, Speca A. Biondi M. Quetiapine for tamoxifen-induced insomnia in women with breast cancer. Psychosomatics. 2009;50:159–161. doi: 10.1176/appi.psy.50.2.159. [DOI] [PubMed] [Google Scholar]

[b211] Pollak L, Shpirer I, Rabey JM, Klein C. Schiffer J. Polysomnography in patients with intracranial tumors before and after operation. Acta Neurol. Scand. 2004;109:56–60. doi: 10.1034/j.1600-0404.2003.00176.x. [DOI] [PubMed] [Google Scholar]

[b212] Richardson A. Ream E. The experience of fatigue and other symptoms in patients receiving chemotherapy. Eur. J. Cancer Care (Engl.) 1996;5(Suppl. 2):24–30. doi: 10.1111/j.1365-2354.1996.tb00248.x. [DOI] [PubMed] [Google Scholar]

[b213] Rischer J, Scherwath A, Zander AR, Koch U. Schulz-Kindermann F. Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation. Bone Marrow Transplant. 2009;44:121–128. doi: 10.1038/bmt.2008.430. [DOI] [PubMed] [Google Scholar]

[b214] Servaes P, Verhagen S. Bleijenberg G. Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann. Oncol. 2002;13:589–598. doi: 10.1093/annonc/mdf082. [DOI] [PubMed] [Google Scholar]

[b215] Grov EK, Fossa SD. Dahl AA. Insomnia in elderly cancer survivors–a population-based controlled study of associations with lifestyle, morbidity, and psychosocial factors. Results from the Health Survey of North-Trondelag County (HUNT-2). Insomnia in elderly cancer survivors. Support. Care Cancer. 2011;19:1319–1326. doi: 10.1007/s00520-010-0948-0. [DOI] [PubMed] [Google Scholar]

[b216] Simeit R, Deck R. Conta-Marx B. Sleep management training for cancer patients with insomnia. Support. Care Cancer. 2004;12:176–183. doi: 10.1007/s00520-004-0594-5. [DOI] [PubMed] [Google Scholar]

[b217] Steffen A, Graefe H, Gehrking E, Konig IR. Wollenberg B. Sleep apnoea in patients after treatment of head neck cancer. Acta Otolaryngol. 2009;129:1300–1305. doi: 10.3109/00016480802613113. [DOI] [PubMed] [Google Scholar]

[b218] Thulin H, Kreicbergs U, Wijkstrom H, Steineck G. Henningsohn L. Sleep disturbances decrease self-assessed quality of life in individuals who have undergone cystectomy. J. Urol. 2010;184:198–202. doi: 10.1016/j.juro.2010.03.009. [DOI] [PubMed] [Google Scholar]

[b219] van der Klaauw AA, Dekkers OM, Pereira AM, van Kralingen KW. Romijn JA. Increased daytime somnolence despite normal sleep patterns in patients treated for nonfunctioning pituitary macroadenoma. J. Clin. Endocrinol. Metab. 2007;92:3898–3903. doi: 10.1210/jc.2007-0944. [DOI] [PubMed] [Google Scholar]

[b220] Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, et al. Sleep duration and breast cancer: a prospective cohort study. Cancer Res. 2005;65:9595–9600. doi: 10.1158/0008-5472.CAN-05-2138. [DOI] [PubMed] [Google Scholar]

[b221] Wilcock A, England R, El Khoury B, Frisby J, Howard P, Bell S, et al. The prevalence of nocturnal hypoxemia in advanced cancer. J. Pain Symptom Manage. 2008;36:351–357. doi: 10.1016/j.jpainsymman.2007.11.007. [DOI] [PubMed] [Google Scholar]

[b222] Haest K, Kumar A, Van Calster B, Leunen K, Smeets A, Amant F, et al. Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up. Ann. Oncol. 2012;23:1449–1454. doi: 10.1093/annonc/mdr478. [DOI] [PubMed] [Google Scholar]

[b223] Laugsand EA, Jakobsen G, Kaasa S. Klepstad P. Inadequate symptom control in advanced cancer patients across Europe. Support. Care Cancer. 2011;19:2005–2014. doi: 10.1007/s00520-010-1051-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b224] Manas A, Ciria JP, Fernandez MC, Gonzalvez ML, Morillo V, Perez M, et al. Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health. Clin. Transl. Oncol. 2011;13:656–663. doi: 10.1007/s12094-011-0711-0. [DOI] [PubMed] [Google Scholar]

[b225] Mann E, Smith MJ, Hellier J, Balabanovic JA, Hamed H, Grunfeld EA, et al. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol. 2012;13:309–318. doi: 10.1016/S1470-2045(11)70364-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b226] Rostock M, Fischer J, Mumm A, Stammwitz U, Saller R. Bartsch HH. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints—a prospective observational study. Gynecol. Endocrinol. 2011;27:844–848. doi: 10.3109/09513590.2010.538097. [DOI] [PubMed] [Google Scholar]

[b227] Sharma N, Hansen CH, O'Connor M, Thekkumpurath P, Walker J, Kleiboer A, et al. Sleep problems in cancer patients: prevalence and association with distress and pain. Psychooncology. 2012;21:1003–1009. doi: 10.1002/pon.2004. [DOI] [PubMed] [Google Scholar]

[b228] Taskila T, de Boer AG, van Dijk FJ. Verbeek JH. Fatigue and its correlates in cancer patients who had returned to work: a cohort study. Psychooncology. 2011;20:1236–1241. doi: 10.1002/pon.1843. [DOI] [PubMed] [Google Scholar]

[b229] Malone M, Harris AL. Luscombe DK. Assessment of the impact of cancer on work, recreation, home management and sleep using a general health status measure. J. R. Soc. Med. 1994;87:386–389. doi: 10.1177/014107689408700705. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b230] Banthia R, Malcarne VL, Ko CM, Varni JW. Sadler GR. Fatigued breast cancer survivors: the role of sleep quality, depressed mood, stage and age. Psychol. Health. 2009;24:965–980. doi: 10.1080/08870440802110831. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b231] Akechi T, Okuyama T, Akizuki N, Shimizu K, Inagaki M, Fujimori M, et al. Associated and predictive factors of sleep disturbance in advanced cancer patients. Psychooncology. 2007;16:888–894. doi: 10.1002/pon.1122. [DOI] [PubMed] [Google Scholar]

[b232] Barichello E, Sawada NO, Sonobe HM. Zago MM. Quality of sleep in postoperative surgical oncologic patients. Rev. Lat. Am. Enfermagem. 2009;17:481–488. doi: 10.1590/s0104-11692009000400008. [DOI] [PubMed] [Google Scholar]

[b233] Beck SL, Berger AM, Barsevick AM, Wong B, Stewart KA. Dudley WN. Sleep quality after initial chemotherapy for breast cancer. Support. Care Cancer. 2010;18:679–689. doi: 10.1007/s00520-009-0662-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b234] Cankurtaran ES, Ozalp E, Soygur H, Akbiyik DI, Turhan L. Alkis N. Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine. Support. Care Cancer. 2008;16:1291–1298. doi: 10.1007/s00520-008-0425-1. [DOI] [PubMed] [Google Scholar]

[b235] Chen ML, Yu CT. Yang CH. Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy. Lung Cancer. 2008;62:391–400. doi: 10.1016/j.lungcan.2008.03.016. [DOI] [PubMed] [Google Scholar]

[b236] Furlani R. Ceolim MF. Sleep quality of women with gynecological and breast cancer. Rev. Lat. Am. Enfermagem. 2006;14:872–878. doi: 10.1590/s0104-11692006000600007. [DOI] [PubMed] [Google Scholar]

[b237] Israel Y, Cervantes O, Abrahao M, Ceccon FP, Marques Filho MF, Nascimento LA, et al. Obstructive sleep apnea in patients undergoing supracricoid horizontal or frontolateral vertical partial laryngectomy. Otolaryngol. Head Neck Surg. 2006;135:911–916. doi: 10.1016/j.otohns.2006.02.030. [DOI] [PubMed] [Google Scholar]

[b238] Kim SW, Shin IS, Kim JM, Kim YC, Kim KS, Kim KM, et al. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. Psychiatry Clin. Neurosci. 2008;62:75–83. doi: 10.1111/j.1440-1819.2007.01778.x. [DOI] [PubMed] [Google Scholar]

[b239] Kuo HH, Chiu MJ, Liao WC. Hwang SL. Quality of sleep and related factors during chemotherapy in patients with stage I/II breast cancer. J. Formos. Med. Assoc. 2006;105:64–69. doi: 10.1016/S0929-6646(09)60110-8. [DOI] [PubMed] [Google Scholar]

[b240] Matsuo N. Morita T. Efficacy, safety, and cost effectiveness of intravenous midazolam and flunitrazepam for primary insomnia in terminally ill patients with cancer: a retrospective multicenter audit study. J. Palliat. Med. 2007;10:1054–1062. doi: 10.1089/jpm.2007.0016. [DOI] [PubMed] [Google Scholar]

[b241] Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Galanos A. Vlahos L. Depression, hopelessness, and sleep in cancer patients' desire for death. Int. J. Psychiatry Med. 2007;37:201–211. doi: 10.2190/0509-7332-388N-566W. [DOI] [PubMed] [Google Scholar]

[b242] Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Gennatas K, Smyrniotis V, et al. The relationship of subjective sleep quality, pain, and quality of life in advanced cancer patients. Sleep. 2007;30:737–742. doi: 10.1093/sleep/30.6.737. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b243] Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Patiraki E, Galanos A, et al. Sleep quality in advanced cancer patients. J. Psychosom. Res. 2007;62:527–533. doi: 10.1016/j.jpsychores.2006.11.008. [DOI] [PubMed] [Google Scholar]

[b244] Taguchi T, Yano M. Kido Y. Influence of bright light therapy on postoperative patients: a pilot study. Intensive Crit. Care Nurs. 2007;23:289–297. doi: 10.1016/j.iccn.2007.04.004. [DOI] [PubMed] [Google Scholar]

[b245] Wang RC, Wang SJ, Chang YC. Lin CC. Mood state and quality of sleep in cancer pain patients: a comparison to chronic daily headache. J. Pain Symptom Manage. 2007;33:32–39. doi: 10.1016/j.jpainsymman.2006.06.013. [DOI] [PubMed] [Google Scholar]

[b246] Wang SY, Tsai CM, Chen BC, Lin CH. Lin CC. Symptom clusters and relationships to symptom interference with daily life in Taiwanese lung cancer patients. J. Pain Symptom Manage. 2008;35:258–266. doi: 10.1016/j.jpainsymman.2007.03.017. [DOI] [PubMed] [Google Scholar]

[b247] Zhao Y, Wang XS. Li PP. Investigation of common symptoms of cancer and reliability analysis. Chin. J. Integr. Med. 2007;13:195–199. doi: 10.1007/s11655-007-0195-5. [DOI] [PubMed] [Google Scholar]

[b248] Cheng KK. Lee DT. Effects of pain, fatigue, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer. Crit. Rev. Oncol. Hematol. 2011;78:127–137. doi: 10.1016/j.critrevonc.2010.03.002. [DOI] [PubMed] [Google Scholar]

[b249] Colagiuri B, Christensen S, Jensen AB, Price MA, Butow PN. Zachariae R. Prevalence and predictors of sleep difficulty in a national cohort of women with primary breast cancer three to four months postsurgery. J. Pain Symptom Manage. 2011;42:710–720. doi: 10.1016/j.jpainsymman.2011.02.012. [DOI] [PubMed] [Google Scholar]

[b250] Demiralp M, Oflaz F. Komurcu S. Effects of relaxation training on sleep quality and fatigue in patients with breast cancer undergoing adjuvant chemotherapy. J. Clin. Nurs. 2010;19:1073–1083. doi: 10.1111/j.1365-2702.2009.03037.x. [DOI] [PubMed] [Google Scholar]

[b251] Evangelista AL. Santos EM. Cluster of symptoms in women with breast cancer treated with curative intent. Support. Care Cancer. 2012;20:1499–1506. doi: 10.1007/s00520-011-1238-1. [DOI] [PubMed] [Google Scholar]

[b252] Huang TW. Lin CC. The mediating effects of depression on sleep disturbance and fatigue: symptom clusters in patients with hepatocellular carcinoma. Cancer Nurs. 2009;32:398–403. doi: 10.1097/NCC.0b013e3181ac6248. [DOI] [PubMed] [Google Scholar]

[b253] Humpel N. Iverson DC. Sleep quality, fatigue and physical activity following a cancer diagnosis. Eur. J. Cancer Care (Engl.) 2010;19:761–768. doi: 10.1111/j.1365-2354.2009.01126.x. [DOI] [PubMed] [Google Scholar]

[b254] Mystakidou K, Parpa E, Tsilika E, Gennatas C, Galanos A. Vlahos L. How is sleep quality affected by the psychological and symptom distress of advanced cancer patients? Palliat. Med. 2009;23:46–53. doi: 10.1177/0269216308098088. [DOI] [PubMed] [Google Scholar]

[b255] Qian W, Haight J, Poon I, Enepekides D. Higgins KM. Sleep apnea in patients with oral cavity and oropharyngeal cancer after surgery and chemoradiation therapy. Otolaryngol. Head Neck Surg. 2010;143:248–252. doi: 10.1016/j.otohns.2010.02.032. [DOI] [PubMed] [Google Scholar]

[b256] Vadiraja SH, Rao MR, Nagendra RH, Nagarathna R, Rekha M, Vanitha N, et al. Effects of yoga on symptom management in breast cancer patients: a randomized controlled trial. Int. J. Yoga. 2009;2:73–79. doi: 10.4103/0973-6131.60048. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b257] Wang SY, Chang HJ. Lin CC. Sleep disturbances among patients with non-small cell lung cancer in Taiwan: congruence between sleep log and actigraphy. Cancer Nurs. 2010;33:E11–E17. doi: 10.1097/NCC.0b013e3181b3278e. [DOI] [PubMed] [Google Scholar]

[b258] Yang HL, Chen XP, Lee KC, Fang FF. Chao YF. The effects of warm-water footbath on relieving fatigue and insomnia of the gynecologic cancer patients on chemotherapy. Cancer Nurs. 2010;33:454–460. doi: 10.1097/NCC.0b013e3181d761c1. [DOI] [PubMed] [Google Scholar]

[b259] Tzeng JI, Fu YW. Lin CC. Validity and reliability of the Taiwanese version of the Pittsburgh Sleep Quality Index in cancer patients. Int. J. Nurs. Stud. 2012;49:102–108. doi: 10.1016/j.ijnurstu.2011.08.004. [DOI] [PubMed] [Google Scholar]

[b260] Chu TL, Yu WP, Chen SC, Peng HL. Wu MJ. Comparison of differences and determinants between presence and absence of sleep disturbance in hepatocellular carcinoma patients. Cancer Nurs. 2011;34:354–360. doi: 10.1097/NCC.0b013e3182037bf3. [DOI] [PubMed] [Google Scholar]

[b261] Feng Y, Wang XY, Li SD, Zhang Y, Wang HM, Li M, et al. Clinical research of acupuncture on malignant tumor patients for improving depression and sleep quality. J. Tradit. Chin. Med. 2011;31:199–202. doi: 10.1016/s0254-6272(11)60042-3. [DOI] [PubMed] [Google Scholar]

[b262] Courneya KS, Sellar CM, Trinh L, Forbes CC, Stevinson C, McNeely ML, et al. A randomized trial of aerobic exercise and sleep quality in lymphoma patients receiving chemotherapy or no treatments. Cancer Epidemiol. Biomarkers Prev. 2012;21:887–894. doi: 10.1158/1055-9965.EPI-12-0075. [DOI] [PubMed] [Google Scholar]

[b263] Hofso K, Miaskowski C, Bjordal K, Cooper BA. Rustoen T. Previous chemotherapy influences the symptom experience and quality of life of women with breast cancer prior to radiation therapy. Cancer Nurs. 2012;35:167–177. doi: 10.1097/NCC.0b013e31821f5eb5. [DOI] [PubMed] [Google Scholar]

[b264] Jane SW, Chen SL, Wilkie DJ, Lin YC, Foreman SW, Beaton RD, et al. Effects of massage on pain, mood status, relaxation, and sleep in Taiwanese patients with metastatic bone pain: a randomized clinical trial. Pain. 2011;152:2432–2442. doi: 10.1016/j.pain.2011.06.021. [DOI] [PubMed] [Google Scholar]

[b265] Kim HJ, Barsevick AM, Beck SL. Dudley W. Clinical subgroups of a psychoneurologic symptom cluster in women receiving treatment for breast cancer: a secondary analysis. Oncol. Nurs. Forum. 2012;39:E20–E30. doi: 10.1188/12.ONF.E20-E30. [DOI] [PubMed] [Google Scholar]

[b266] Kotronoulas GC, Papadopoulou CN, Papapetrou A. Patiraki E. Psychometric evaluation and feasibility of the Greek Pittsburgh Sleep Quality Index (GR-PSQI) in patients with cancer receiving chemotherapy. Support. Care Cancer. 2011;19:1831–1840. doi: 10.1007/s00520-010-1025-4. [DOI] [PubMed] [Google Scholar]

[b267] Liu Y, Xi QS, Xia S, Zhuang L, Zheng W. Yu S. Association between symptoms and their severity with survival time in hospitalized patients with far advanced cancer. J. Palliat. Med. 2011;25:682–690. doi: 10.1177/0269216311398301. [DOI] [PubMed] [Google Scholar]

[b268] Monas L, Csorba S, Kovalyo M, Zeligman R, Dror YF. Musgrave CF. The relationship of sleep disturbance and symptom severity, symptom interference, and hospitalization among Israeli inpatients with cancer. Oncol. Nurs. Forum. 2012;39:E361–E372. doi: 10.1188/12.ONF.E361-E372. [DOI] [PubMed] [Google Scholar]

[b269] Mota DD, Pimenta CA. Caponero R. Fatigue in colorectal cancer patients: prevalence and associated factors. Rev. Lat. Am. Enfermagem. 2012;20:495–503. doi: 10.1590/s0104-11692012000300010. [DOI] [PubMed] [Google Scholar]

[b270] Berger AM. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol. Nurs. Forum. 1998;25:51–62. [PubMed] [Google Scholar]

[b271] Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W. Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 2003;26:342–392. doi: 10.1093/sleep/26.3.342. [DOI] [PubMed] [Google Scholar]

[b272] Buysse DJ, Reynolds CF, III, Monk TH, Berman SR. Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213. doi: 10.1016/0165-1781(89)90047-4. [DOI] [PubMed] [Google Scholar]

[b273] Espie CA. Insomnia: conceptual issues in the development, persistence, and treatment of sleep disorder in adults. Annu. Rev. Psychol. 2002;53:215–243. doi: 10.1146/annurev.psych.53.100901.135243. [DOI] [PubMed] [Google Scholar]

[b274] Fry JM. Sleep disorders. Med. Clin. North Am. 1987;71:95–110. doi: 10.1016/s0025-7125(16)30885-9. [DOI] [PubMed] [Google Scholar]

[b275] Vena C, Parker K, Allen R, Bliwise D, Jain S. Kimble L. Sleep-wake disturbances and quality of life in patients with advanced lung cancer. Oncol. Nurs. Forum. 2006;33:761–769. doi: 10.1188/06.ONF.761-769. [DOI] [PubMed] [Google Scholar]

[b276] Freedman RR. Roehrs TA. Sleep disturbance in menopause. Menopause. 2007;14:826–829. doi: 10.1097/GME.0b013e3180321a22. [DOI] [PubMed] [Google Scholar]

[b277] Dzaja A, Arber S, Hislop J, Kerkhofs M, Kopp C, Pollmacher T, et al. Women's sleep in health and disease. J. Psychiatr. Res. 2005;39:55–76. doi: 10.1016/j.jpsychires.2004.05.008. [DOI] [PubMed] [Google Scholar]

PERMALINK

Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?

Julie L Otte

Janet S Carpenter

Shalini Manchanda

Kevin L Rand

Todd C Skaar

Michael Weaver

Yelena Chernyak

Xin Zhong

Christele Igega

Carol Landis

Abstract

Introduction

Methods

Results

Figure 1.

Description of studies

Sleep-specific characteristics of studies

Table 1.

Discussion

Limitations of this review

Implications for practice

Conclusion

Conflict of Interest

References

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?

Julie L Otte

Janet S Carpenter

Shalini Manchanda

Kevin L Rand

Todd C Skaar

Michael Weaver

Yelena Chernyak

Xin Zhong

Christele Igega

Carol Landis

Abstract

Introduction

Methods

Results

Figure 1.

Description of studies

Sleep-specific characteristics of studies

Table 1.

Discussion

Limitations of this review

Implications for practice

Conclusion

Conflict of Interest

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases